id	sid	tid	token	lemma	pos
aijmsr-196	1	1	copyright	copyright	NOUN
aijmsr-196	1	2	©	©	PROPN
aijmsr-196	1	3	cc	cc	PROPN
aijmsr-196	1	4	-	-	PUNCT
aijmsr-196	1	5	by	by	ADP
aijmsr-196	1	6	-	-	PUNCT
aijmsr-196	1	7	nc	nc	PROPN
aijmsr-196	1	8	2018	2018	NUM
aijmsr-196	1	9	,	,	PUNCT
aijmsr-196	1	10	cribfb	cribfb	VERB
aijmsr-196	1	11	|	|	ADV
aijmsr-196	1	12	aijmsr	aijmsr	VERB
aijmsr-196	1	13	american	american	PROPN
aijmsr-196	1	14	international	international	PROPN
aijmsr-196	1	15	journal	journal	PROPN
aijmsr-196	1	16	of	of	ADP
aijmsr-196	1	17	multidisciplinary	multidisciplinary	ADJ
aijmsr-196	1	18	scientific	scientific	ADJ
aijmsr-196	1	19	research	research	NOUN
aijmsr-196	1	20	;	;	PUNCT
aijmsr-196	1	21	vol	vol	NOUN
aijmsr-196	1	22	.	.	NOUN
aijmsr-196	1	23	4	4	NUM
aijmsr-196	1	24	,	,	PUNCT
aijmsr-196	1	25	no	no	INTJ
aijmsr-196	1	26	.	.	NOUN
aijmsr-196	1	27	1	1	NUM
aijmsr-196	1	28	;	;	PUNCT
aijmsr-196	1	29	2018	2018	NUM
aijmsr-196	1	30	issn	issn	VERB
aijmsr-196	1	31	2638	2638	NUM
aijmsr-196	1	32	-	-	SYM
aijmsr-196	1	33	1249	1249	NUM
aijmsr-196	1	34	e	e	NOUN
aijmsr-196	1	35	-	-	PROPN
aijmsr-196	1	36	issn	issn	PROPN
aijmsr-196	1	37	2638	2638	NUM
aijmsr-196	1	38	-	-	SYM
aijmsr-196	1	39	1273	1273	NUM
aijmsr-196	1	40	impact	impact	NOUN
aijmsr-196	1	41	factor	factor	NOUN
aijmsr-196	1	42	:	:	PUNCT
aijmsr-196	1	43	5.8	5.8	NUM
aijmsr-196	1	44	research	research	NOUN
aijmsr-196	1	45	article	article	NOUN
aijmsr-196	1	46	published	publish	VERB
aijmsr-196	1	47	by	by	ADP
aijmsr-196	1	48	centre	centre	NOUN
aijmsr-196	1	49	for	for	ADP
aijmsr-196	1	50	research	research	NOUN
aijmsr-196	1	51	on	on	ADP
aijmsr-196	1	52	islamic	islamic	ADJ
aijmsr-196	1	53	banking	banking	PROPN
aijmsr-196	1	54	&	&	CCONJ
aijmsr-196	1	55	finance	finance	PROPN
aijmsr-196	1	56	and	and	CCONJ
aijmsr-196	1	57	business	business	NOUN
aijmsr-196	1	58	17	17	NUM
aijmsr-196	1	59	higher	high	ADJ
aijmsr-196	1	60	serum	serum	NOUN
aijmsr-196	1	61	levels	level	NOUN
aijmsr-196	1	62	of	of	ADP
aijmsr-196	1	63	stromelisyn	stromelisyn	NOUN
aijmsr-196	1	64	2	2	NUM
aijmsr-196	1	65	(	(	PUNCT
aijmsr-196	1	66	mmp10	mmp10	PROPN
aijmsr-196	1	67	)	)	PUNCT
aijmsr-196	1	68	but	but	CCONJ
aijmsr-196	1	69	not	not	PART
aijmsr-196	1	70	matrilysin	matrilysin	VERB
aijmsr-196	1	71	(	(	PUNCT
aijmsr-196	1	72	mmp7	mmp7	PROPN
aijmsr-196	1	73	)	)	PUNCT
aijmsr-196	1	74	in	in	ADP
aijmsr-196	1	75	patients	patient	NOUN
aijmsr-196	1	76	with	with	ADP
aijmsr-196	1	77	end	end	NOUN
aijmsr-196	1	78	-	-	PUNCT
aijmsr-196	1	79	stage	stage	NOUN
aijmsr-196	1	80	chronic	chronic	ADJ
aijmsr-196	1	81	kidney	kidney	NOUN
aijmsr-196	1	82	disease	disease	NOUN
aijmsr-196	1	83	on	on	ADP
aijmsr-196	1	84	chroniodialysis	chroniodialysis	NOUN
aijmsr-196	1	85	tsvetelina	tsvetelina	NOUN
aijmsr-196	1	86	velikova	velikova	ADP
aijmsr-196	1	87	1	1	NUM
aijmsr-196	1	88	,	,	PUNCT
aijmsr-196	1	89	toni	toni	NOUN
aijmsr-196	1	90	velikov	velikov	PROPN
aijmsr-196	1	91	2	2	NUM
aijmsr-196	1	92	&	&	CCONJ
aijmsr-196	1	93	georgi	georgi	PROPN
aijmsr-196	1	94	mihailov	mihailov	PROPN
aijmsr-196	1	95	3	3	NUM
aijmsr-196	1	96	1	1	NUM
aijmsr-196	1	97	clinical	clinical	ADJ
aijmsr-196	1	98	immunology	immunology	NOUN
aijmsr-196	1	99	,	,	PUNCT
aijmsr-196	1	100	university	university	NOUN
aijmsr-196	1	101	hospital	hospital	NOUN
aijmsr-196	1	102	lozenetz	lozenetz	NOUN
aijmsr-196	1	103	,	,	PUNCT
aijmsr-196	1	104	kozyak	kozyak	NOUN
aijmsr-196	1	105	1	1	NUM
aijmsr-196	1	106	str	str	NOUN
aijmsr-196	1	107	.	.	PUNCT
aijmsr-196	1	108	,	,	PUNCT
aijmsr-196	1	109	1407	1407	NUM
aijmsr-196	1	110	sofia	sofia	PROPN
aijmsr-196	1	111	,	,	PUNCT
aijmsr-196	1	112	bulgaria	bulgaria	PROPN
aijmsr-196	1	113	2	2	NUM
aijmsr-196	1	114	department	department	NOUN
aijmsr-196	1	115	of	of	ADP
aijmsr-196	1	116	emergency	emergency	PROPN
aijmsr-196	1	117	edicine	edicine	NOUN
aijmsr-196	1	118	,	,	PUNCT
aijmsr-196	1	119	university	university	NOUN
aijmsr-196	1	120	hospital	hospital	NOUN
aijmsr-196	1	121	–	–	PUNCT
aijmsr-196	1	122	tsaritsa	tsaritsa	VERB
aijmsr-196	1	123	joanna	joanna	NOUN
aijmsr-196	1	124	,	,	PUNCT
aijmsr-196	1	125	byalo	byalo	NOUN
aijmsr-196	1	126	more	more	ADJ
aijmsr-196	1	127	8	8	NUM
aijmsr-196	1	128	str	str	NUM
aijmsr-196	1	129	,	,	PUNCT
aijmsr-196	1	130	1527	1527	NUM
aijmsr-196	1	131	sofia	sofia	PROPN
aijmsr-196	1	132	,	,	PUNCT
aijmsr-196	1	133	bulgaria	bulgaria	PROPN
aijmsr-196	1	134	3	3	NUM
aijmsr-196	1	135	clinic	clinic	NOUN
aijmsr-196	1	136	of	of	ADP
aijmsr-196	1	137	chemodialysis	chemodialysis	NOUN
aijmsr-196	1	138	,	,	PUNCT
aijmsr-196	1	139	university	university	NOUN
aijmsr-196	1	140	hospital	hospital	NOUN
aijmsr-196	1	141	–	–	PUNCT
aijmsr-196	1	142	tsaritsa	tsaritsa	VERB
aijmsr-196	1	143	joanna	joanna	NOUN
aijmsr-196	1	144	–	–	PUNCT
aijmsr-196	1	145	isul	isul	NOUN
aijmsr-196	1	146	,	,	PUNCT
aijmsr-196	1	147	byalo	byalo	NOUN
aijmsr-196	1	148	more	more	ADJ
aijmsr-196	1	149	8	8	NUM
aijmsr-196	1	150	str	str	NUM
aijmsr-196	1	151	,	,	PUNCT
aijmsr-196	1	152	1527	1527	NUM
aijmsr-196	1	153	sofia	sofia	PROPN
aijmsr-196	1	154	,	,	PUNCT
aijmsr-196	1	155	bulgaria	bulgaria	PROPN
aijmsr-196	1	156	correspondence	correspondence	NOUN
aijmsr-196	1	157	:	:	PUNCT
aijmsr-196	1	158	corresponding	correspond	VERB
aijmsr-196	1	159	author	author	NOUN
aijmsr-196	1	160	:	:	PUNCT
aijmsr-196	1	161	tsvetelina	tsvetelina	PROPN
aijmsr-196	1	162	v.	v.	CCONJ
aijmsr-196	1	163	velikova	velikova	PROPN
aijmsr-196	1	164	,	,	PUNCT
aijmsr-196	1	165	md	md	PROPN
aijmsr-196	1	166	,	,	PUNCT
aijmsr-196	1	167	phd	phd	NOUN
aijmsr-196	1	168	clinical	clinical	ADJ
aijmsr-196	1	169	immunology	immunology	NOUN
aijmsr-196	1	170	,	,	PUNCT
aijmsr-196	1	171	university	university	NOUN
aijmsr-196	1	172	hospital	hospital	NOUN
aijmsr-196	1	173	lozenetz	lozenetz	NOUN
aijmsr-196	1	174	,	,	PUNCT
aijmsr-196	1	175	kozyak	kozyak	NOUN
aijmsr-196	1	176	1	1	NUM
aijmsr-196	1	177	str	str	NOUN
aijmsr-196	1	178	.	.	PUNCT
aijmsr-196	1	179	,	,	PUNCT
aijmsr-196	1	180	1407	1407	NUM
aijmsr-196	1	181	sofia	sofia	PROPN
aijmsr-196	1	182	,	,	PUNCT
aijmsr-196	1	183	bulgaria	bulgaria	PROPN
aijmsr-196	1	184	,	,	PUNCT
aijmsr-196	1	185	mobile	mobile	NOUN
aijmsr-196	1	186	:	:	PUNCT
aijmsr-196	1	187	00359883306049	00359883306049	NUM
aijmsr-196	1	188	,	,	PUNCT
aijmsr-196	1	189	e	e	NOUN
aijmsr-196	1	190	-	-	NOUN
aijmsr-196	1	191	mail	mail	NOUN
aijmsr-196	1	192	:	:	PUNCT
aijmsr-196	1	193	tsvelikova@medfac.musofia.bg	tsvelikova@medfac.musofia.bg	ADJ
aijmsr-196	1	194	to	to	PART
aijmsr-196	1	195	cite	cite	VERB
aijmsr-196	1	196	this	this	DET
aijmsr-196	1	197	article	article	NOUN
aijmsr-196	1	198	:	:	PUNCT
aijmsr-196	1	199	velikova	velikova	PROPN
aijmsr-196	1	200	,	,	PUNCT
aijmsr-196	1	201	t.	t.	PROPN
aijmsr-196	1	202	,	,	PUNCT
aijmsr-196	1	203	velikov	velikov	PROPN
aijmsr-196	1	204	,	,	PUNCT
aijmsr-196	1	205	t.	t.	PROPN
aijmsr-196	1	206	,	,	PUNCT
aijmsr-196	1	207	&	&	CCONJ
aijmsr-196	1	208	mihailov	mihailov	PROPN
aijmsr-196	1	209	,	,	PUNCT
aijmsr-196	1	210	g.	g.	PROPN
aijmsr-196	1	211	(	(	PUNCT
aijmsr-196	1	212	2018	2018	NUM
aijmsr-196	1	213	)	)	PUNCT
aijmsr-196	1	214	.	.	PUNCT
aijmsr-196	2	1	higher	high	ADJ
aijmsr-196	2	2	serum	serum	NOUN
aijmsr-196	2	3	levels	level	NOUN
aijmsr-196	2	4	of	of	ADP
aijmsr-196	2	5	stromelisyn	stromelisyn	NOUN
aijmsr-196	2	6	2	2	NUM
aijmsr-196	2	7	(	(	PUNCT
aijmsr-196	2	8	mmp10	mmp10	PROPN
aijmsr-196	2	9	)	)	PUNCT
aijmsr-196	2	10	but	but	CCONJ
aijmsr-196	2	11	not	not	PART
aijmsr-196	2	12	matrilysin	matrilysin	VERB
aijmsr-196	2	13	(	(	PUNCT
aijmsr-196	2	14	mmp7	mmp7	PROPN
aijmsr-196	2	15	)	)	PUNCT
aijmsr-196	2	16	in	in	ADP
aijmsr-196	2	17	patients	patient	NOUN
aijmsr-196	2	18	with	with	ADP
aijmsr-196	2	19	end	end	NOUN
aijmsr-196	2	20	-	-	PUNCT
aijmsr-196	2	21	stage	stage	NOUN
aijmsr-196	2	22	chronic	chronic	ADJ
aijmsr-196	2	23	kidney	kidney	NOUN
aijmsr-196	2	24	disease	disease	NOUN
aijmsr-196	2	25	on	on	ADP
aijmsr-196	2	26	chroniodialysis	chroniodialysis	NOUN
aijmsr-196	2	27	.	.	PUNCT
aijmsr-196	3	1	american	american	PROPN
aijmsr-196	3	2	international	international	PROPN
aijmsr-196	3	3	journal	journal	PROPN
aijmsr-196	3	4	of	of	ADP
aijmsr-196	3	5	multidisciplinary	multidisciplinary	ADJ
aijmsr-196	3	6	scientific	scientific	ADJ
aijmsr-196	3	7	research	research	NOUN
aijmsr-196	3	8	,	,	PUNCT
aijmsr-196	3	9	4(1	4(1	NOUN
aijmsr-196	3	10	)	)	PUNCT
aijmsr-196	3	11	,	,	PUNCT
aijmsr-196	3	12	17	17	NUM
aijmsr-196	3	13	-	-	SYM
aijmsr-196	3	14	21	21	NUM
aijmsr-196	3	15	.	.	PUNCT
aijmsr-196	4	1	retrieved	retrieve	VERB
aijmsr-196	4	2	from	from	ADP
aijmsr-196	4	3	http://www.cribfb.com/journal/index.php/aijmsr/article/view/196	http://www.cribfb.com/journal/index.php/aijmsr/article/view/196	PROPN
aijmsr-196	4	4	received	receive	VERB
aijmsr-196	4	5	:	:	PUNCT
aijmsr-196	4	6	october	october	PROPN
aijmsr-196	4	7	13	13	NUM
aijmsr-196	4	8	,	,	PUNCT
aijmsr-196	4	9	2018	2018	NUM
aijmsr-196	4	10	accepted	accepted	AUX
aijmsr-196	4	11	:	:	PUNCT
aijmsr-196	4	12	october	october	PROPN
aijmsr-196	4	13	30	30	NUM
aijmsr-196	4	14	,	,	PUNCT
aijmsr-196	4	15	2018	2018	NUM
aijmsr-196	4	16	online	online	ADV
aijmsr-196	4	17	published	publish	VERB
aijmsr-196	4	18	:	:	PUNCT
aijmsr-196	4	19	november	november	PROPN
aijmsr-196	4	20	9	9	NUM
aijmsr-196	4	21	,	,	PUNCT
aijmsr-196	4	22	2018	2018	NUM
aijmsr-196	4	23	abstract	abstract	ADJ
aijmsr-196	4	24	matrix	matrix	NOUN
aijmsr-196	4	25	metalloproteinases	metalloproteinase	NOUN
aijmsr-196	4	26	(	(	PUNCT
aijmsr-196	4	27	mmps	mmp	NOUN
aijmsr-196	4	28	)	)	PUNCT
aijmsr-196	4	29	are	be	AUX
aijmsr-196	4	30	endopeptidases	endopeptidase	NOUN
aijmsr-196	4	31	with	with	ADP
aijmsr-196	4	32	proteolytic	proteolytic	ADJ
aijmsr-196	4	33	activity	activity	NOUN
aijmsr-196	4	34	against	against	ADP
aijmsr-196	4	35	components	component	NOUN
aijmsr-196	4	36	of	of	ADP
aijmsr-196	4	37	extracellular	extracellular	ADJ
aijmsr-196	4	38	matrix	matrix	NOUN
aijmsr-196	4	39	,	,	PUNCT
aijmsr-196	4	40	such	such	ADJ
aijmsr-196	4	41	as	as	ADP
aijmsr-196	4	42	collagen	collagen	NOUN
aijmsr-196	4	43	and	and	CCONJ
aijmsr-196	4	44	elastin	elastin	NOUN
aijmsr-196	4	45	,	,	PUNCT
aijmsr-196	4	46	which	which	PRON
aijmsr-196	4	47	are	be	AUX
aijmsr-196	4	48	involved	involve	VERB
aijmsr-196	4	49	in	in	ADP
aijmsr-196	4	50	many	many	ADJ
aijmsr-196	4	51	biological	biological	ADJ
aijmsr-196	4	52	and	and	CCONJ
aijmsr-196	4	53	pathophysiological	pathophysiological	ADJ
aijmsr-196	4	54	processes	process	NOUN
aijmsr-196	4	55	in	in	ADP
aijmsr-196	4	56	humans	human	NOUN
aijmsr-196	4	57	.	.	PUNCT
aijmsr-196	5	1	there	there	PRON
aijmsr-196	5	2	is	be	VERB
aijmsr-196	5	3	some	some	DET
aijmsr-196	5	4	evidence	evidence	NOUN
aijmsr-196	5	5	for	for	ADP
aijmsr-196	5	6	mmps	mmp	NOUN
aijmsr-196	5	7	`	`	PUNCT
aijmsr-196	5	8	role	role	NOUN
aijmsr-196	5	9	in	in	ADP
aijmsr-196	5	10	nephrogenesis	nephrogenesis	NOUN
aijmsr-196	5	11	,	,	PUNCT
aijmsr-196	5	12	renal	renal	ADJ
aijmsr-196	5	13	damage	damage	NOUN
aijmsr-196	5	14	,	,	PUNCT
aijmsr-196	5	15	and	and	CCONJ
aijmsr-196	5	16	remodeling	remodeling	NOUN
aijmsr-196	5	17	,	,	PUNCT
aijmsr-196	5	18	such	such	ADJ
aijmsr-196	5	19	as	as	ADP
aijmsr-196	5	20	mmp-7	mmp-7	DET
aijmsr-196	5	21	(	(	PUNCT
aijmsr-196	5	22	matrilysin	matrilysin	NOUN
aijmsr-196	5	23	)	)	PUNCT
aijmsr-196	5	24	and	and	CCONJ
aijmsr-196	5	25	mmp-10	mmp-10	PROPN
aijmsr-196	5	26	(	(	PUNCT
aijmsr-196	5	27	stromelysin	stromelysin	PROPN
aijmsr-196	5	28	)	)	PUNCT
aijmsr-196	5	29	.	.	PUNCT
aijmsr-196	6	1	however	however	ADV
aijmsr-196	6	2	,	,	PUNCT
aijmsr-196	6	3	the	the	DET
aijmsr-196	6	4	implication	implication	NOUN
aijmsr-196	6	5	of	of	ADP
aijmsr-196	6	6	mmps	mmp	NOUN
aijmsr-196	6	7	in	in	ADP
aijmsr-196	6	8	the	the	DET
aijmsr-196	6	9	pathogenetic	pathogenetic	ADJ
aijmsr-196	6	10	renal	renal	ADJ
aijmsr-196	6	11	changes	change	NOUN
aijmsr-196	6	12	in	in	ADP
aijmsr-196	6	13	patients	patient	NOUN
aijmsr-196	6	14	with	with	ADP
aijmsr-196	6	15	chronic	chronic	ADJ
aijmsr-196	6	16	kidney	kidney	NOUN
aijmsr-196	6	17	disease	disease	NOUN
aijmsr-196	6	18	(	(	PUNCT
aijmsr-196	6	19	ckd	ckd	NOUN
aijmsr-196	6	20	)	)	PUNCT
aijmsr-196	6	21	is	be	AUX
aijmsr-196	6	22	poorly	poorly	ADV
aijmsr-196	6	23	understood	understand	VERB
aijmsr-196	6	24	.	.	PUNCT
aijmsr-196	7	1	therefore	therefore	ADV
aijmsr-196	7	2	,	,	PUNCT
aijmsr-196	7	3	we	we	PRON
aijmsr-196	7	4	aimed	aim	VERB
aijmsr-196	7	5	to	to	PART
aijmsr-196	7	6	measure	measure	VERB
aijmsr-196	7	7	the	the	DET
aijmsr-196	7	8	serum	serum	NOUN
aijmsr-196	7	9	levels	level	NOUN
aijmsr-196	7	10	of	of	ADP
aijmsr-196	7	11	circulating	circulate	VERB
aijmsr-196	7	12	mmp-7	mmp-7	NUM
aijmsr-196	7	13	and	and	CCONJ
aijmsr-196	7	14	mmp-10	mmp-10	NOUN
aijmsr-196	7	15	in	in	ADP
aijmsr-196	7	16	patients	patient	NOUN
aijmsr-196	7	17	at	at	ADP
aijmsr-196	7	18	different	different	ADJ
aijmsr-196	7	19	stages	stage	NOUN
aijmsr-196	7	20	of	of	ADP
aijmsr-196	7	21	chronic	chronic	ADJ
aijmsr-196	7	22	kidney	kidney	NOUN
aijmsr-196	7	23	disease	disease	NOUN
aijmsr-196	7	24	and	and	CCONJ
aijmsr-196	7	25	to	to	PART
aijmsr-196	7	26	analyze	analyze	VERB
aijmsr-196	7	27	the	the	DET
aijmsr-196	7	28	impact	impact	NOUN
aijmsr-196	7	29	of	of	ADP
aijmsr-196	7	30	mmp-7	mmp-7	NUM
aijmsr-196	7	31	and	and	CCONJ
aijmsr-196	7	32	mmp-10	mmp-10	NOUN
aijmsr-196	7	33	on	on	ADP
aijmsr-196	7	34	the	the	DET
aijmsr-196	7	35	renal	renal	ADJ
aijmsr-196	7	36	disease	disease	NOUN
aijmsr-196	7	37	burden	burden	NOUN
aijmsr-196	7	38	of	of	ADP
aijmsr-196	7	39	these	these	DET
aijmsr-196	7	40	patients	patient	NOUN
aijmsr-196	7	41	.	.	PUNCT
aijmsr-196	8	1	in	in	ADP
aijmsr-196	8	2	our	our	PRON
aijmsr-196	8	3	study	study	NOUN
aijmsr-196	8	4	,	,	PUNCT
aijmsr-196	8	5	we	we	PRON
aijmsr-196	8	6	have	have	AUX
aijmsr-196	8	7	evaluated	evaluate	VERB
aijmsr-196	8	8	80	80	NUM
aijmsr-196	8	9	persons	person	NOUN
aijmsr-196	8	10	–	–	PUNCT
aijmsr-196	8	11	20	20	NUM
aijmsr-196	8	12	with	with	ADP
aijmsr-196	8	13	ckd	ckd	PROPN
aijmsr-196	8	14	(	(	PUNCT
aijmsr-196	8	15	ii	ii	PROPN
aijmsr-196	8	16	–	–	PUNCT
aijmsr-196	8	17	iv	iv	NUM
aijmsr-196	8	18	stage	stage	NOUN
aijmsr-196	8	19	)	)	PUNCT
aijmsr-196	8	20	,	,	PUNCT
aijmsr-196	8	21	20	20	NUM
aijmsr-196	8	22	with	with	ADP
aijmsr-196	8	23	end	end	NOUN
aijmsr-196	8	24	-	-	PUNCT
aijmsr-196	8	25	stage	stage	NOUN
aijmsr-196	8	26	ckd	ckd	NOUN
aijmsr-196	8	27	on	on	ADP
aijmsr-196	8	28	chronic	chronic	ADJ
aijmsr-196	8	29	hemodialysis	hemodialysis	NOUN
aijmsr-196	8	30	,	,	PUNCT
aijmsr-196	8	31	and	and	CCONJ
aijmsr-196	8	32	40	40	NUM
aijmsr-196	8	33	age	age	NOUN
aijmsr-196	8	34	and	and	CCONJ
aijmsr-196	8	35	sexmatched	sexmatche	VERB
aijmsr-196	8	36	control	control	NOUN
aijmsr-196	8	37	subjects	subject	NOUN
aijmsr-196	8	38	:	:	PUNCT
aijmsr-196	8	39	20	20	NUM
aijmsr-196	8	40	with	with	ADP
aijmsr-196	8	41	isolated	isolated	ADJ
aijmsr-196	8	42	arterial	arterial	ADJ
aijmsr-196	8	43	hypertension	hypertension	NOUN
aijmsr-196	8	44	and	and	CCONJ
aijmsr-196	8	45	20	20	NUM
aijmsr-196	8	46	healthy	healthy	ADJ
aijmsr-196	8	47	persons	person	NOUN
aijmsr-196	8	48	.	.	PUNCT
aijmsr-196	9	1	the	the	DET
aijmsr-196	9	2	serum	serum	NOUN
aijmsr-196	9	3	samples	sample	NOUN
aijmsr-196	9	4	were	be	AUX
aijmsr-196	9	5	tested	test	VERB
aijmsr-196	9	6	for	for	ADP
aijmsr-196	9	7	mmp-7	mmp-7	NUM
aijmsr-196	9	8	and	and	CCONJ
aijmsr-196	9	9	mmp-10	mmp-10	NUM
aijmsr-196	9	10	by	by	ADP
aijmsr-196	9	11	performing	perform	VERB
aijmsr-196	9	12	enzyme	enzyme	NOUN
aijmsr-196	9	13	immunoassay	immunoassay	ADJ
aijmsr-196	9	14	method	method	NOUN
aijmsr-196	9	15	.	.	PUNCT
aijmsr-196	10	1	serum	serum	NOUN
aijmsr-196	10	2	levels	level	NOUN
aijmsr-196	10	3	of	of	ADP
aijmsr-196	10	4	both	both	DET
aijmsr-196	10	5	investigated	investigate	VERB
aijmsr-196	10	6	mmps	mmp	NOUN
aijmsr-196	10	7	were	be	AUX
aijmsr-196	10	8	most	most	ADV
aijmsr-196	10	9	increased	increase	VERB
aijmsr-196	10	10	in	in	ADP
aijmsr-196	10	11	end	end	NOUN
aijmsr-196	10	12	-	-	PUNCT
aijmsr-196	10	13	stage	stage	NOUN
aijmsr-196	10	14	ckd	ckd	NOUN
aijmsr-196	10	15	patients	patient	NOUN
aijmsr-196	10	16	on	on	ADP
aijmsr-196	10	17	hemodialysis	hemodialysis	NOUN
aijmsr-196	10	18	.	.	PUNCT
aijmsr-196	11	1	the	the	DET
aijmsr-196	11	2	concentration	concentration	NOUN
aijmsr-196	11	3	of	of	ADP
aijmsr-196	11	4	mmp10	mmp10	PROPN
aijmsr-196	11	5	was	be	AUX
aijmsr-196	11	6	significantly	significantly	ADV
aijmsr-196	11	7	higher	high	ADJ
aijmsr-196	11	8	in	in	ADP
aijmsr-196	11	9	ckd	ckd	PROPN
aijmsr-196	11	10	patients	patient	NOUN
aijmsr-196	11	11	on	on	ADP
aijmsr-196	11	12	chroniodialysis	chroniodialysis	NOUN
aijmsr-196	11	13	than	than	ADP
aijmsr-196	11	14	healthy	healthy	ADJ
aijmsr-196	11	15	persons	person	NOUN
aijmsr-196	11	16	(	(	PUNCT
aijmsr-196	11	17	p	p	X
aijmsr-196	11	18	<	<	X
aijmsr-196	11	19	0.001	0.001	NUM
aijmsr-196	11	20	)	)	PUNCT
aijmsr-196	11	21	,	,	PUNCT
aijmsr-196	11	22	and	and	CCONJ
aijmsr-196	11	23	patients	patient	NOUN
aijmsr-196	11	24	with	with	ADP
aijmsr-196	11	25	isolated	isolated	ADJ
aijmsr-196	11	26	arterial	arterial	ADJ
aijmsr-196	11	27	hypertension	hypertension	NOUN
aijmsr-196	11	28	(	(	PUNCT
aijmsr-196	11	29	p	p	X
aijmsr-196	11	30	<	<	X
aijmsr-196	11	31	0.001	0.001	NUM
aijmsr-196	11	32	)	)	PUNCT
aijmsr-196	11	33	and	and	CCONJ
aijmsr-196	11	34	patients	patient	NOUN
aijmsr-196	11	35	at	at	ADP
aijmsr-196	11	36	different	different	ADJ
aijmsr-196	11	37	stages	stage	NOUN
aijmsr-196	11	38	of	of	ADP
aijmsr-196	11	39	ckd	ckd	PROPN
aijmsr-196	11	40	(	(	PUNCT
aijmsr-196	11	41	p	p	NOUN
aijmsr-196	11	42	=	=	NOUN
aijmsr-196	11	43	0.037	0.037	NUM
aijmsr-196	11	44	)	)	PUNCT
aijmsr-196	11	45	.	.	PUNCT
aijmsr-196	12	1	to	to	PART
aijmsr-196	12	2	conclude	conclude	VERB
aijmsr-196	12	3	,	,	PUNCT
aijmsr-196	12	4	it	it	PRON
aijmsr-196	12	5	is	be	AUX
aijmsr-196	12	6	possible	possible	ADJ
aijmsr-196	12	7	that	that	SCONJ
aijmsr-196	12	8	the	the	DET
aijmsr-196	12	9	increased	increase	VERB
aijmsr-196	12	10	levels	level	NOUN
aijmsr-196	12	11	of	of	ADP
aijmsr-196	12	12	mmp-10	mmp-10	PROPN
aijmsr-196	12	13	could	could	AUX
aijmsr-196	12	14	be	be	AUX
aijmsr-196	12	15	associated	associate	VERB
aijmsr-196	12	16	with	with	ADP
aijmsr-196	12	17	poor	poor	ADJ
aijmsr-196	12	18	prognosis	prognosis	NOUN
aijmsr-196	12	19	and	and	CCONJ
aijmsr-196	12	20	eventually	eventually	ADV
aijmsr-196	12	21	need	need	VERB
aijmsr-196	12	22	for	for	ADP
aijmsr-196	12	23	dialysis	dialysis	NOUN
aijmsr-196	12	24	treatment	treatment	NOUN
aijmsr-196	12	25	at	at	ADP
aijmsr-196	12	26	earlier	early	ADJ
aijmsr-196	12	27	stages	stage	NOUN
aijmsr-196	12	28	.	.	PUNCT
aijmsr-196	13	1	we	we	PRON
aijmsr-196	13	2	hypothesize	hypothesize	VERB
aijmsr-196	13	3	that	that	SCONJ
aijmsr-196	13	4	ckd	ckd	PROPN
aijmsr-196	13	5	is	be	AUX
aijmsr-196	13	6	associated	associate	VERB
aijmsr-196	13	7	with	with	ADP
aijmsr-196	13	8	alterations	alteration	NOUN
aijmsr-196	13	9	of	of	ADP
aijmsr-196	13	10	mmps	mmp	NOUN
aijmsr-196	13	11	and	and	CCONJ
aijmsr-196	13	12	that	that	PRON
aijmsr-196	13	13	may	may	AUX
aijmsr-196	13	14	be	be	AUX
aijmsr-196	13	15	related	relate	VERB
aijmsr-196	13	16	to	to	ADP
aijmsr-196	13	17	the	the	DET
aijmsr-196	13	18	severity	severity	NOUN
aijmsr-196	13	19	of	of	ADP
aijmsr-196	13	20	atherosclerosis	atherosclerosis	NOUN
aijmsr-196	13	21	in	in	ADP
aijmsr-196	13	22	this	this	DET
aijmsr-196	13	23	clinical	clinical	ADJ
aijmsr-196	13	24	setting	setting	NOUN
aijmsr-196	13	25	.	.	PUNCT
aijmsr-196	14	1	keywords	keyword	NOUN
aijmsr-196	14	2	:	:	PUNCT
aijmsr-196	14	3	chronic	chronic	ADJ
aijmsr-196	14	4	kidney	kidney	NOUN
aijmsr-196	14	5	disease	disease	NOUN
aijmsr-196	14	6	,	,	PUNCT
aijmsr-196	14	7	matrix	matrix	NOUN
aijmsr-196	14	8	metalloproteinases	metalloproteinase	NOUN
aijmsr-196	14	9	,	,	PUNCT
aijmsr-196	14	10	mmp-7	mmp-7	ADV
aijmsr-196	14	11	,	,	PUNCT
aijmsr-196	14	12	matrilysin	matrilysin	NOUN
aijmsr-196	14	13	,	,	PUNCT
aijmsr-196	14	14	mmp-10	mmp-10	PROPN
aijmsr-196	14	15	,	,	PUNCT
aijmsr-196	14	16	stromelysin	stromelysin	NOUN
aijmsr-196	14	17	2	2	NUM
aijmsr-196	14	18	,	,	PUNCT
aijmsr-196	14	19	chroniodialysis	chroniodialysis	NOUN
aijmsr-196	14	20	,	,	PUNCT
aijmsr-196	14	21	end	end	NOUN
aijmsr-196	14	22	-	-	PUNCT
aijmsr-196	14	23	stage	stage	NOUN
aijmsr-196	14	24	kidney	kidney	NOUN
aijmsr-196	14	25	disease	disease	NOUN
aijmsr-196	14	26	.	.	PUNCT
aijmsr-196	15	1	copyright	copyright	NOUN
aijmsr-196	15	2	©	©	PROPN
aijmsr-196	15	3	cc	cc	PROPN
aijmsr-196	15	4	-	-	PUNCT
aijmsr-196	15	5	by	by	ADP
aijmsr-196	15	6	-	-	PUNCT
aijmsr-196	15	7	nc	nc	PROPN
aijmsr-196	15	8	2018	2018	NUM
aijmsr-196	15	9	,	,	PUNCT
aijmsr-196	15	10	cribfb	cribfb	VERB
aijmsr-196	15	11	|	|	CCONJ
aijmsr-196	15	12	aijmsr	aijmsr	NOUN
aijmsr-196	15	13	www.cribfb.com/journal/index.php/aijmsr	www.cribfb.com/journal/index.php/aijmsr	VERB
aijmsr-196	15	14	american	american	PROPN
aijmsr-196	15	15	international	international	PROPN
aijmsr-196	15	16	journal	journal	PROPN
aijmsr-196	15	17	of	of	ADP
aijmsr-196	15	18	multidisciplinary	multidisciplinary	ADJ
aijmsr-196	15	19	scientific	scientific	ADJ
aijmsr-196	15	20	research	research	NOUN
aijmsr-196	15	21	vol	vol	NOUN
aijmsr-196	15	22	.	.	PROPN
aijmsr-196	16	1	4	4	NUM
aijmsr-196	16	2	,	,	PUNCT
aijmsr-196	16	3	no	no	INTJ
aijmsr-196	16	4	.	.	NOUN
aijmsr-196	16	5	1	1	NUM
aijmsr-196	16	6	;	;	PUNCT
aijmsr-196	16	7	2018	2018	NUM
aijmsr-196	16	8	18	18	NUM
aijmsr-196	16	9	1	1	NUM
aijmsr-196	16	10	.	.	PUNCT
aijmsr-196	17	1	introduction	introduction	NOUN
aijmsr-196	17	2	matrix	matrix	NOUN
aijmsr-196	17	3	metalloproteinases	metalloproteinase	NOUN
aijmsr-196	17	4	(	(	PUNCT
aijmsr-196	17	5	mmps	mmp	NOUN
aijmsr-196	17	6	)	)	PUNCT
aijmsr-196	17	7	are	be	AUX
aijmsr-196	17	8	a	a	DET
aijmsr-196	17	9	group	group	NOUN
aijmsr-196	17	10	of	of	ADP
aijmsr-196	17	11	zinc	zinc	NOUN
aijmsr-196	17	12	-	-	PUNCT
aijmsr-196	17	13	containing	contain	VERB
aijmsr-196	17	14	and	and	CCONJ
aijmsr-196	17	15	zinc	zinc	NOUN
aijmsr-196	17	16	-	-	PUNCT
aijmsr-196	17	17	dependent	dependent	ADJ
aijmsr-196	17	18	endopeptidases	endopeptidase	NOUN
aijmsr-196	17	19	which	which	PRON
aijmsr-196	17	20	possess	possess	VERB
aijmsr-196	17	21	the	the	DET
aijmsr-196	17	22	capacity	capacity	NOUN
aijmsr-196	17	23	to	to	PART
aijmsr-196	17	24	cleave	cleave	VERB
aijmsr-196	17	25	components	component	NOUN
aijmsr-196	17	26	of	of	ADP
aijmsr-196	17	27	extracellular	extracellular	ADJ
aijmsr-196	17	28	matrix	matrix	NOUN
aijmsr-196	17	29	,	,	PUNCT
aijmsr-196	17	30	mostly	mostly	ADV
aijmsr-196	17	31	type	type	NOUN
aijmsr-196	17	32	iv	iv	NUM
aijmsr-196	17	33	collagen	collagen	NOUN
aijmsr-196	17	34	and	and	CCONJ
aijmsr-196	17	35	elastin	elastin	NOUN
aijmsr-196	17	36	.	.	PUNCT
aijmsr-196	18	1	1,2	1,2	NUM
aijmsr-196	18	2	there	there	PRON
aijmsr-196	18	3	have	have	AUX
aijmsr-196	18	4	been	be	AUX
aijmsr-196	18	5	identified	identify	VERB
aijmsr-196	18	6	28	28	NUM
aijmsr-196	18	7	different	different	ADJ
aijmsr-196	18	8	mmps	mmp	NOUN
aijmsr-196	18	9	in	in	ADP
aijmsr-196	18	10	humans	human	NOUN
aijmsr-196	18	11	.	.	PUNCT
aijmsr-196	19	1	3,4	3,4	NUM
aijmsr-196	19	2	mmps	mmp	NOUN
aijmsr-196	19	3	are	be	AUX
aijmsr-196	19	4	secreted	secrete	VERB
aijmsr-196	19	5	in	in	ADP
aijmsr-196	19	6	a	a	DET
aijmsr-196	19	7	non	non	ADJ
aijmsr-196	19	8	-	-	ADJ
aijmsr-196	19	9	active	active	ADJ
aijmsr-196	19	10	form	form	NOUN
aijmsr-196	19	11	which	which	PRON
aijmsr-196	19	12	requires	require	VERB
aijmsr-196	19	13	activation	activation	NOUN
aijmsr-196	19	14	to	to	PART
aijmsr-196	19	15	develop	develop	VERB
aijmsr-196	19	16	proteolytic	proteolytic	ADJ
aijmsr-196	19	17	activity	activity	NOUN
aijmsr-196	19	18	.	.	PUNCT
aijmsr-196	20	1	several	several	ADJ
aijmsr-196	20	2	mmps	mmp	NOUN
aijmsr-196	20	3	are	be	AUX
aijmsr-196	20	4	involved	involve	VERB
aijmsr-196	20	5	in	in	ADP
aijmsr-196	20	6	a	a	DET
aijmsr-196	20	7	range	range	NOUN
aijmsr-196	20	8	of	of	ADP
aijmsr-196	20	9	physiological	physiological	ADJ
aijmsr-196	20	10	processes	process	NOUN
aijmsr-196	20	11	,	,	PUNCT
aijmsr-196	20	12	such	such	ADJ
aijmsr-196	20	13	as	as	ADP
aijmsr-196	20	14	embryogenesis	embryogenesis	NOUN
aijmsr-196	20	15	,	,	PUNCT
aijmsr-196	20	16	normal	normal	ADJ
aijmsr-196	20	17	tissue	tissue	NOUN
aijmsr-196	20	18	remodeling	remodeling	NOUN
aijmsr-196	20	19	,	,	PUNCT
aijmsr-196	20	20	wound	wound	NOUN
aijmsr-196	20	21	healing	healing	NOUN
aijmsr-196	20	22	and	and	CCONJ
aijmsr-196	20	23	angiogenesis	angiogenesis	NOUN
aijmsr-196	20	24	.	.	PUNCT
aijmsr-196	21	1	5	5	NUM
aijmsr-196	21	2	in	in	ADP
aijmsr-196	21	3	healthy	healthy	ADJ
aijmsr-196	21	4	tissue	tissue	NOUN
aijmsr-196	21	5	,	,	PUNCT
aijmsr-196	21	6	the	the	DET
aijmsr-196	21	7	activity	activity	NOUN
aijmsr-196	21	8	of	of	ADP
aijmsr-196	21	9	mmps	mmp	NOUN
aijmsr-196	21	10	is	be	AUX
aijmsr-196	21	11	ordinarily	ordinarily	ADV
aijmsr-196	21	12	low	low	ADJ
aijmsr-196	21	13	,	,	PUNCT
aijmsr-196	21	14	but	but	CCONJ
aijmsr-196	21	15	the	the	DET
aijmsr-196	21	16	increased	increase	VERB
aijmsr-196	21	17	expression	expression	NOUN
aijmsr-196	21	18	and	and	CCONJ
aijmsr-196	21	19	activity	activity	NOUN
aijmsr-196	21	20	are	be	AUX
aijmsr-196	21	21	observed	observe	VERB
aijmsr-196	21	22	mainly	mainly	ADV
aijmsr-196	21	23	due	due	ADP
aijmsr-196	21	24	to	to	ADP
aijmsr-196	21	25	loss	loss	NOUN
aijmsr-196	21	26	of	of	ADP
aijmsr-196	21	27	the	the	DET
aijmsr-196	21	28	control	control	NOUN
aijmsr-196	21	29	mechanisms	mechanism	NOUN
aijmsr-196	21	30	.	.	PUNCT
aijmsr-196	22	1	specific	specific	ADJ
aijmsr-196	22	2	mmps	mmp	NOUN
aijmsr-196	22	3	are	be	AUX
aijmsr-196	22	4	described	describe	VERB
aijmsr-196	22	5	to	to	PART
aijmsr-196	22	6	play	play	VERB
aijmsr-196	22	7	a	a	DET
aijmsr-196	22	8	role	role	NOUN
aijmsr-196	22	9	in	in	ADP
aijmsr-196	22	10	some	some	DET
aijmsr-196	22	11	pathological	pathological	ADJ
aijmsr-196	22	12	processes	process	NOUN
aijmsr-196	22	13	such	such	ADJ
aijmsr-196	22	14	as	as	ADP
aijmsr-196	22	15	inflammation	inflammation	NOUN
aijmsr-196	22	16	,	,	PUNCT
aijmsr-196	22	17	tissue	tissue	NOUN
aijmsr-196	22	18	ulceration	ulceration	NOUN
aijmsr-196	22	19	,	,	PUNCT
aijmsr-196	22	20	cancer	cancer	NOUN
aijmsr-196	22	21	,	,	PUNCT
aijmsr-196	22	22	bone	bone	NOUN
aijmsr-196	22	23	turnover	turnover	NOUN
aijmsr-196	22	24	,	,	PUNCT
aijmsr-196	22	25	nephritis	nephritis	NOUN
aijmsr-196	22	26	,	,	PUNCT
aijmsr-196	22	27	and	and	CCONJ
aijmsr-196	22	28	fibrosis	fibrosis	NOUN
aijmsr-196	22	29	.	.	PUNCT
aijmsr-196	23	1	6,7	6,7	NUM
aijmsr-196	23	2	cleaving	cleave	VERB
aijmsr-196	23	3	mostly	mostly	ADV
aijmsr-196	23	4	the	the	DET
aijmsr-196	23	5	type	type	NOUN
aijmsr-196	23	6	iv	iv	NUM
aijmsr-196	23	7	collagen	collagen	NOUN
aijmsr-196	23	8	the	the	DET
aijmsr-196	23	9	main	main	ADJ
aijmsr-196	23	10	component	component	NOUN
aijmsr-196	23	11	of	of	ADP
aijmsr-196	23	12	vessels	vessel	NOUN
aijmsr-196	23	13	and	and	CCONJ
aijmsr-196	23	14	basement	basement	NOUN
aijmsr-196	23	15	membrane	membrane	NOUN
aijmsr-196	23	16	,	,	PUNCT
aijmsr-196	23	17	mmps	mmp	NOUN
aijmsr-196	23	18	were	be	AUX
aijmsr-196	23	19	thought	think	VERB
aijmsr-196	23	20	to	to	PART
aijmsr-196	23	21	be	be	AUX
aijmsr-196	23	22	involved	involve	VERB
aijmsr-196	23	23	in	in	ADP
aijmsr-196	23	24	the	the	DET
aijmsr-196	23	25	induction	induction	NOUN
aijmsr-196	23	26	,	,	PUNCT
aijmsr-196	23	27	progression	progression	NOUN
aijmsr-196	23	28	,	,	PUNCT
aijmsr-196	23	29	and	and	CCONJ
aijmsr-196	23	30	repair	repair	NOUN
aijmsr-196	23	31	of	of	ADP
aijmsr-196	23	32	renal	renal	ADJ
aijmsr-196	23	33	disease	disease	NOUN
aijmsr-196	23	34	.	.	PUNCT
aijmsr-196	24	1	2	2	NUM
aijmsr-196	24	2	the	the	DET
aijmsr-196	24	3	expression	expression	NOUN
aijmsr-196	24	4	of	of	ADP
aijmsr-196	24	5	mmps	mmp	NOUN
aijmsr-196	24	6	in	in	ADP
aijmsr-196	24	7	the	the	DET
aijmsr-196	24	8	kidney	kidney	NOUN
aijmsr-196	24	9	is	be	AUX
aijmsr-196	24	10	complex	complex	ADJ
aijmsr-196	24	11	,	,	PUNCT
aijmsr-196	24	12	species	specie	NOUN
aijmsr-196	24	13	dependent	dependent	ADJ
aijmsr-196	24	14	but	but	CCONJ
aijmsr-196	24	15	their	their	PRON
aijmsr-196	24	16	localization	localization	NOUN
aijmsr-196	24	17	has	have	AUX
aijmsr-196	24	18	not	not	PART
aijmsr-196	24	19	been	be	AUX
aijmsr-196	24	20	thoroughly	thoroughly	ADV
aijmsr-196	24	21	characterized	characterize	VERB
aijmsr-196	24	22	.	.	PUNCT
aijmsr-196	25	1	4	4	NUM
aijmsr-196	25	2	some	some	DET
aijmsr-196	25	3	studies	study	NOUN
aijmsr-196	25	4	revealed	reveal	VERB
aijmsr-196	25	5	recently	recently	ADV
aijmsr-196	25	6	that	that	SCONJ
aijmsr-196	25	7	mmp-7	mmp-7	DET
aijmsr-196	25	8	(	(	PUNCT
aijmsr-196	25	9	matrilysin	matrilysin	NOUN
aijmsr-196	25	10	)	)	PUNCT
aijmsr-196	25	11	is	be	AUX
aijmsr-196	25	12	expressed	express	VERB
aijmsr-196	25	13	in	in	ADP
aijmsr-196	25	14	human	human	ADJ
aijmsr-196	25	15	renal	renal	ADJ
aijmsr-196	25	16	tubular	tubular	ADJ
aijmsr-196	25	17	disease	disease	NOUN
aijmsr-196	25	18	and	and	CCONJ
aijmsr-196	25	19	mouse	mouse	NOUN
aijmsr-196	25	20	models	model	NOUN
aijmsr-196	25	21	of	of	ADP
aijmsr-196	25	22	acute	acute	ADJ
aijmsr-196	25	23	renal	renal	ADJ
aijmsr-196	25	24	tubular	tubular	ADJ
aijmsr-196	25	25	injury	injury	NOUN
aijmsr-196	25	26	and	and	CCONJ
aijmsr-196	25	27	fibrosis	fibrosis	NOUN
aijmsr-196	25	28	8	8	NUM
aijmsr-196	25	29	whereas	whereas	SCONJ
aijmsr-196	25	30	mmp-10	mmp-10	PROPN
aijmsr-196	25	31	(	(	PUNCT
aijmsr-196	25	32	stromelysin	stromelysin	NOUN
aijmsr-196	25	33	2	2	NUM
aijmsr-196	25	34	)	)	PUNCT
aijmsr-196	25	35	is	be	AUX
aijmsr-196	25	36	associated	associate	VERB
aijmsr-196	25	37	with	with	ADP
aijmsr-196	25	38	atherosclerotic	atherosclerotic	ADJ
aijmsr-196	25	39	changes	change	NOUN
aijmsr-196	25	40	,	,	PUNCT
aijmsr-196	25	41	particularly	particularly	ADV
aijmsr-196	25	42	in	in	ADP
aijmsr-196	25	43	patients	patient	NOUN
aijmsr-196	25	44	with	with	ADP
aijmsr-196	25	45	chronic	chronic	ADJ
aijmsr-196	25	46	kidney	kidney	NOUN
aijmsr-196	25	47	disease	disease	NOUN
aijmsr-196	25	48	(	(	PUNCT
aijmsr-196	25	49	ckd	ckd	PROPN
aijmsr-196	25	50	)	)	PUNCT
aijmsr-196	25	51	.	.	PUNCT
aijmsr-196	26	1	9	9	NUM
aijmsr-196	26	2	however	however	ADV
aijmsr-196	26	3	,	,	PUNCT
aijmsr-196	26	4	the	the	DET
aijmsr-196	26	5	roles	role	NOUN
aijmsr-196	26	6	of	of	ADP
aijmsr-196	26	7	mmps	mmp	NOUN
aijmsr-196	26	8	in	in	ADP
aijmsr-196	26	9	the	the	DET
aijmsr-196	26	10	pathogenetic	pathogenetic	ADJ
aijmsr-196	26	11	changes	change	NOUN
aijmsr-196	26	12	in	in	ADP
aijmsr-196	26	13	the	the	DET
aijmsr-196	26	14	kidney	kidney	NOUN
aijmsr-196	26	15	at	at	ADP
aijmsr-196	26	16	ckd	ckd	PROPN
aijmsr-196	26	17	are	be	AUX
aijmsr-196	26	18	poorly	poorly	ADV
aijmsr-196	26	19	understood	understand	VERB
aijmsr-196	26	20	,	,	PUNCT
aijmsr-196	26	21	partly	partly	ADV
aijmsr-196	26	22	because	because	SCONJ
aijmsr-196	26	23	there	there	PRON
aijmsr-196	26	24	are	be	VERB
aijmsr-196	26	25	a	a	DET
aijmsr-196	26	26	limited	limited	ADJ
aijmsr-196	26	27	number	number	NOUN
aijmsr-196	26	28	of	of	ADP
aijmsr-196	26	29	investigations	investigation	NOUN
aijmsr-196	26	30	regarding	regard	VERB
aijmsr-196	26	31	the	the	DET
aijmsr-196	26	32	mmps	mmp	NOUN
aijmsr-196	26	33	in	in	ADP
aijmsr-196	26	34	the	the	DET
aijmsr-196	26	35	kidney	kidney	NOUN
aijmsr-196	26	36	and	and	CCONJ
aijmsr-196	26	37	their	their	PRON
aijmsr-196	26	38	role	role	NOUN
aijmsr-196	26	39	in	in	ADP
aijmsr-196	26	40	nephrogenesis	nephrogenesis	NOUN
aijmsr-196	26	41	,	,	PUNCT
aijmsr-196	26	42	renal	renal	ADJ
aijmsr-196	26	43	damage	damage	NOUN
aijmsr-196	26	44	and	and	CCONJ
aijmsr-196	26	45	renal	renal	ADJ
aijmsr-196	26	46	remodeling	remodeling	NOUN
aijmsr-196	26	47	1	1	NUM
aijmsr-196	26	48	.	.	PUNCT
aijmsr-196	27	1	therefore	therefore	ADV
aijmsr-196	27	2	,	,	PUNCT
aijmsr-196	27	3	we	we	PRON
aijmsr-196	27	4	aimed	aim	VERB
aijmsr-196	27	5	to	to	PART
aijmsr-196	27	6	measure	measure	VERB
aijmsr-196	27	7	the	the	DET
aijmsr-196	27	8	serum	serum	NOUN
aijmsr-196	27	9	levels	level	NOUN
aijmsr-196	27	10	of	of	ADP
aijmsr-196	27	11	circulating	circulate	VERB
aijmsr-196	27	12	mmp-7	mmp-7	NUM
aijmsr-196	27	13	and	and	CCONJ
aijmsr-196	27	14	mmp-10	mmp-10	NOUN
aijmsr-196	27	15	in	in	ADP
aijmsr-196	27	16	a	a	DET
aijmsr-196	27	17	cohort	cohort	NOUN
aijmsr-196	27	18	of	of	ADP
aijmsr-196	27	19	bulgarian	bulgarian	ADJ
aijmsr-196	27	20	patients	patient	NOUN
aijmsr-196	27	21	at	at	ADP
aijmsr-196	27	22	different	different	ADJ
aijmsr-196	27	23	stages	stage	NOUN
aijmsr-196	27	24	of	of	ADP
aijmsr-196	27	25	ckd	ckd	NOUN
aijmsr-196	27	26	and	and	CCONJ
aijmsr-196	27	27	analyzed	analyze	VERB
aijmsr-196	27	28	the	the	DET
aijmsr-196	27	29	impact	impact	NOUN
aijmsr-196	27	30	of	of	ADP
aijmsr-196	27	31	mmps	mmp	NOUN
aijmsr-196	27	32	in	in	ADP
aijmsr-196	27	33	the	the	DET
aijmsr-196	27	34	renal	renal	ADJ
aijmsr-196	27	35	disease	disease	NOUN
aijmsr-196	27	36	burden	burden	NOUN
aijmsr-196	27	37	of	of	ADP
aijmsr-196	27	38	these	these	DET
aijmsr-196	27	39	patients	patient	NOUN
aijmsr-196	27	40	.	.	PUNCT
aijmsr-196	28	1	2	2	X
aijmsr-196	28	2	.	.	X
aijmsr-196	28	3	material	material	NOUN
aijmsr-196	28	4	and	and	CCONJ
aijmsr-196	28	5	methods	method	NOUN
aijmsr-196	28	6	2.1subjects	2.1subject	NOUN
aijmsr-196	28	7	we	we	PRON
aijmsr-196	28	8	enrolled	enrol	VERB
aijmsr-196	28	9	80	80	NUM
aijmsr-196	28	10	persons	person	NOUN
aijmsr-196	28	11	in	in	ADP
aijmsr-196	28	12	our	our	PRON
aijmsr-196	28	13	study	study	NOUN
aijmsr-196	28	14	–	–	PUNCT
aijmsr-196	28	15	20	20	NUM
aijmsr-196	28	16	with	with	ADP
aijmsr-196	28	17	ckd	ckd	PROPN
aijmsr-196	28	18	(	(	PUNCT
aijmsr-196	28	19	ii	ii	PROPN
aijmsr-196	28	20	–	–	PUNCT
aijmsr-196	28	21	iv	iv	NUM
aijmsr-196	28	22	stage	stage	NOUN
aijmsr-196	28	23	)	)	PUNCT
aijmsr-196	28	24	and	and	CCONJ
aijmsr-196	28	25	20	20	NUM
aijmsr-196	28	26	with	with	ADP
aijmsr-196	28	27	end	end	NOUN
aijmsr-196	28	28	-	-	PUNCT
aijmsr-196	28	29	stage	stage	NOUN
aijmsr-196	28	30	ckd	ckd	NOUN
aijmsr-196	28	31	on	on	ADP
aijmsr-196	28	32	chronic	chronic	ADJ
aijmsr-196	28	33	hemodialysis	hemodialysis	NOUN
aijmsr-196	28	34	at	at	ADP
aijmsr-196	28	35	mean	mean	NOUN
aijmsr-196	28	36	age	age	NOUN
aijmsr-196	28	37	57	57	NUM
aijmsr-196	28	38	±	±	NUM
aijmsr-196	28	39	16	16	NUM
aijmsr-196	28	40	years	year	NOUN
aijmsr-196	28	41	(	(	PUNCT
aijmsr-196	28	42	34.7	34.7	NUM
aijmsr-196	28	43	%	%	NOUN
aijmsr-196	28	44	females	female	NOUN
aijmsr-196	28	45	)	)	PUNCT
aijmsr-196	28	46	,	,	PUNCT
aijmsr-196	28	47	and	and	CCONJ
aijmsr-196	28	48	40	40	NUM
aijmsr-196	28	49	control	control	NOUN
aijmsr-196	28	50	subjects	subject	NOUN
aijmsr-196	28	51	20	20	NUM
aijmsr-196	28	52	with	with	ADP
aijmsr-196	28	53	isolated	isolated	ADJ
aijmsr-196	28	54	arterial	arterial	ADJ
aijmsr-196	28	55	hypertension	hypertension	NOUN
aijmsr-196	28	56	and	and	CCONJ
aijmsr-196	28	57	20	20	NUM
aijmsr-196	28	58	healthy	healthy	ADJ
aijmsr-196	28	59	persons	person	NOUN
aijmsr-196	28	60	,	,	PUNCT
aijmsr-196	28	61	all	all	DET
aijmsr-196	28	62	age	age	NOUN
aijmsr-196	28	63	,	,	PUNCT
aijmsr-196	28	64	and	and	CCONJ
aijmsr-196	28	65	sex	sex	NOUN
aijmsr-196	28	66	-	-	PUNCT
aijmsr-196	28	67	matched	match	VERB
aijmsr-196	28	68	.	.	PUNCT
aijmsr-196	29	1	the	the	DET
aijmsr-196	29	2	patients	patient	NOUN
aijmsr-196	29	3	in	in	ADP
aijmsr-196	29	4	each	each	DET
aijmsr-196	29	5	group	group	NOUN
aijmsr-196	29	6	were	be	AUX
aijmsr-196	29	7	included	include	VERB
aijmsr-196	29	8	after	after	ADP
aijmsr-196	29	9	previously	previously	ADV
aijmsr-196	29	10	considerate	considerate	ADJ
aijmsr-196	29	11	inclusion	inclusion	NOUN
aijmsr-196	29	12	criteria	criterion	NOUN
aijmsr-196	29	13	.	.	PUNCT
aijmsr-196	30	1	all	all	DET
aijmsr-196	30	2	patients	patient	NOUN
aijmsr-196	30	3	were	be	AUX
aijmsr-196	30	4	informed	inform	VERB
aijmsr-196	30	5	about	about	ADP
aijmsr-196	30	6	the	the	DET
aijmsr-196	30	7	purpose	purpose	NOUN
aijmsr-196	30	8	of	of	ADP
aijmsr-196	30	9	the	the	DET
aijmsr-196	30	10	experiment	experiment	NOUN
aijmsr-196	30	11	and	and	CCONJ
aijmsr-196	30	12	had	have	AUX
aijmsr-196	30	13	signed	sign	VERB
aijmsr-196	30	14	written	write	VERB
aijmsr-196	30	15	confirmed	confirm	VERB
aijmsr-196	30	16	consent	consent	NOUN
aijmsr-196	30	17	approved	approve	VERB
aijmsr-196	30	18	by	by	ADP
aijmsr-196	30	19	the	the	DET
aijmsr-196	30	20	ethic	ethic	ADJ
aijmsr-196	30	21	committee	committee	NOUN
aijmsr-196	30	22	of	of	ADP
aijmsr-196	30	23	the	the	DET
aijmsr-196	30	24	medical	medical	ADJ
aijmsr-196	30	25	university	university	PROPN
aijmsr-196	30	26	of	of	ADP
aijmsr-196	30	27	sofia	sofia	PROPN
aijmsr-196	30	28	and	and	CCONJ
aijmsr-196	30	29	the	the	DET
aijmsr-196	30	30	ethic	ethic	ADJ
aijmsr-196	30	31	committee	committee	PROPN
aijmsr-196	30	32	of	of	ADP
aijmsr-196	30	33	university	university	PROPN
aijmsr-196	30	34	hospital	hospital	NOUN
aijmsr-196	30	35	“	"	PUNCT
aijmsr-196	30	36	tsaritsa	tsaritsa	VERB
aijmsr-196	30	37	joanna	joanna	PROPN
aijmsr-196	30	38	–	–	PUNCT
aijmsr-196	30	39	isul	isul	NOUN
aijmsr-196	30	40	,	,	PUNCT
aijmsr-196	30	41	”	"	PUNCT
aijmsr-196	30	42	sofia	sofia	NOUN
aijmsr-196	30	43	.	.	PUNCT
aijmsr-196	31	1	2.2	2.2	NUM
aijmsr-196	31	2	chroniodialysis	chroniodialysis	NOUN
aijmsr-196	31	3	regimen	regimen	VERB
aijmsr-196	31	4	the	the	DET
aijmsr-196	31	5	chronic	chronic	ADJ
aijmsr-196	31	6	dialysis	dialysis	NOUN
aijmsr-196	31	7	for	for	ADP
aijmsr-196	31	8	patients	patient	NOUN
aijmsr-196	31	9	with	with	ADP
aijmsr-196	31	10	end	end	NOUN
aijmsr-196	31	11	-	-	PUNCT
aijmsr-196	31	12	stage	stage	NOUN
aijmsr-196	31	13	ckd	ckd	NOUN
aijmsr-196	31	14	was	be	AUX
aijmsr-196	31	15	performed	perform	VERB
aijmsr-196	31	16	three	three	NUM
aijmsr-196	31	17	times	time	NOUN
aijmsr-196	31	18	a	a	DET
aijmsr-196	31	19	week	week	NOUN
aijmsr-196	31	20	.	.	PUNCT
aijmsr-196	32	1	the	the	DET
aijmsr-196	32	2	serum	serum	NOUN
aijmsr-196	32	3	samples	sample	NOUN
aijmsr-196	32	4	were	be	AUX
aijmsr-196	32	5	obtained	obtain	VERB
aijmsr-196	32	6	after	after	ADP
aijmsr-196	32	7	the	the	DET
aijmsr-196	32	8	dialysis	dialysis	NOUN
aijmsr-196	32	9	cycle	cycle	NOUN
aijmsr-196	32	10	and	and	CCONJ
aijmsr-196	32	11	stored	store	VERB
aijmsr-196	32	12	at	at	ADP
aijmsr-196	32	13	-80	-80	NOUN
aijmsr-196	32	14	°	°	ADP
aijmsr-196	32	15	c	c	NOUN
aijmsr-196	32	16	prior	prior	ADJ
aijmsr-196	32	17	elisa	elisa	PROPN
aijmsr-196	32	18	testing	testing	NOUN
aijmsr-196	32	19	.	.	PUNCT
aijmsr-196	33	1	enzyme	enzyme	NOUN
aijmsr-196	33	2	immunoassays	immunoassay	NOUN
aijmsr-196	33	3	the	the	DET
aijmsr-196	33	4	serum	serum	NOUN
aijmsr-196	33	5	levels	level	NOUN
aijmsr-196	33	6	of	of	ADP
aijmsr-196	33	7	mmp-7	mmp-7	NUM
aijmsr-196	33	8	and	and	CCONJ
aijmsr-196	33	9	mmp-10	mmp-10	PRON
aijmsr-196	33	10	were	be	AUX
aijmsr-196	33	11	measured	measure	VERB
aijmsr-196	33	12	by	by	ADP
aijmsr-196	33	13	elisa	elisa	PROPN
aijmsr-196	33	14	(	(	PUNCT
aijmsr-196	33	15	mmp7	mmp7	PROPN
aijmsr-196	33	16	human	human	PROPN
aijmsr-196	33	17	elisa	elisa	PROPN
aijmsr-196	33	18	kit	kit	PROPN
aijmsr-196	33	19	,	,	PUNCT
aijmsr-196	33	20	mmp10	mmp10	PROPN
aijmsr-196	33	21	human	human	PROPN
aijmsr-196	33	22	elisa	elisa	PROPN
aijmsr-196	33	23	kit	kit	PROPN
aijmsr-196	33	24	,	,	PUNCT
aijmsr-196	33	25	abcam	abcam	PROPN
aijmsr-196	33	26	,	,	PUNCT
aijmsr-196	33	27	uk	uk	PROPN
aijmsr-196	33	28	)	)	PUNCT
aijmsr-196	33	29	.	.	PUNCT
aijmsr-196	34	1	we	we	PRON
aijmsr-196	34	2	strictly	strictly	ADV
aijmsr-196	34	3	followed	follow	VERB
aijmsr-196	34	4	the	the	DET
aijmsr-196	34	5	manufacturer	manufacturer	NOUN
aijmsr-196	34	6	’s	’s	PART
aijmsr-196	34	7	instructions	instruction	NOUN
aijmsr-196	34	8	.	.	PUNCT
aijmsr-196	35	1	statistical	statistical	ADJ
aijmsr-196	35	2	methods	method	NOUN
aijmsr-196	35	3	the	the	DET
aijmsr-196	35	4	row	row	NOUN
aijmsr-196	35	5	data	datum	NOUN
aijmsr-196	35	6	were	be	AUX
aijmsr-196	35	7	statistically	statistically	ADV
aijmsr-196	35	8	evaluated	evaluate	VERB
aijmsr-196	35	9	by	by	ADP
aijmsr-196	35	10	parametric	parametric	ADJ
aijmsr-196	35	11	and	and	CCONJ
aijmsr-196	35	12	non	non	ADJ
aijmsr-196	35	13	-	-	ADJ
aijmsr-196	35	14	parametric	parametric	ADJ
aijmsr-196	35	15	tests	test	NOUN
aijmsr-196	35	16	using	use	VERB
aijmsr-196	35	17	software	software	NOUN
aijmsr-196	35	18	package	package	NOUN
aijmsr-196	35	19	for	for	ADP
aijmsr-196	35	20	statistical	statistical	ADJ
aijmsr-196	35	21	analysis	analysis	NOUN
aijmsr-196	35	22	(	(	PUNCT
aijmsr-196	35	23	spss	spss	PROPN
aijmsr-196	35	24	®	®	PROPN
aijmsr-196	35	25	)	)	PUNCT
aijmsr-196	35	26	,	,	PUNCT
aijmsr-196	35	27	ibm	ibm	PROPN
aijmsr-196	35	28	2009	2009	NUM
aijmsr-196	35	29	,	,	PUNCT
aijmsr-196	35	30	version	version	NOUN
aijmsr-196	35	31	19	19	NUM
aijmsr-196	35	32	(	(	PUNCT
aijmsr-196	35	33	2010	2010	NUM
aijmsr-196	35	34	)	)	PUNCT
aijmsr-196	35	35	and	and	CCONJ
aijmsr-196	35	36	excel	excel	VERB
aijmsr-196	35	37	(	(	PUNCT
aijmsr-196	35	38	2010	2010	NUM
aijmsr-196	35	39	)	)	PUNCT
aijmsr-196	35	40	.	.	PUNCT
aijmsr-196	36	1	differences	difference	NOUN
aijmsr-196	36	2	were	be	AUX
aijmsr-196	36	3	considered	consider	VERB
aijmsr-196	36	4	significant	significant	ADJ
aijmsr-196	36	5	when	when	SCONJ
aijmsr-196	36	6	the	the	DET
aijmsr-196	36	7	p	p	NOUN
aijmsr-196	36	8	-	-	PUNCT
aijmsr-196	36	9	value	value	NOUN
aijmsr-196	36	10	was	be	AUX
aijmsr-196	36	11	less	less	ADJ
aijmsr-196	36	12	than	than	ADP
aijmsr-196	36	13	0.05	0.05	NUM
aijmsr-196	36	14	.	.	PUNCT
aijmsr-196	37	1	3	3	NUM
aijmsr-196	37	2	.	.	NOUN
aijmsr-196	37	3	results	result	VERB
aijmsr-196	37	4	the	the	DET
aijmsr-196	37	5	mean	mean	ADJ
aijmsr-196	37	6	serum	serum	NOUN
aijmsr-196	37	7	levels	level	NOUN
aijmsr-196	37	8	of	of	ADP
aijmsr-196	37	9	mmp-7	mmp-7	NUM
aijmsr-196	37	10	and	and	CCONJ
aijmsr-196	37	11	-10	-10	PROPN
aijmsr-196	37	12	in	in	ADP
aijmsr-196	37	13	all	all	DET
aijmsr-196	37	14	investigated	investigate	VERB
aijmsr-196	37	15	groups	group	NOUN
aijmsr-196	37	16	are	be	AUX
aijmsr-196	37	17	displayed	display	VERB
aijmsr-196	37	18	in	in	ADP
aijmsr-196	37	19	table	table	NOUN
aijmsr-196	37	20	1	1	NUM
aijmsr-196	37	21	.	.	PUNCT
aijmsr-196	37	22	table	table	NOUN
aijmsr-196	37	23	1	1	NUM
aijmsr-196	37	24	.	.	PUNCT
aijmsr-196	38	1	mean	mean	VERB
aijmsr-196	38	2	serum	serum	NOUN
aijmsr-196	38	3	levels	level	NOUN
aijmsr-196	38	4	of	of	ADP
aijmsr-196	38	5	matrix	matrix	NOUN
aijmsr-196	38	6	metalloproteinases-7	metalloproteinases-7	NUM
aijmsr-196	38	7	and	and	CCONJ
aijmsr-196	38	8	10	10	NUM
aijmsr-196	38	9	in	in	ADP
aijmsr-196	38	10	the	the	DET
aijmsr-196	38	11	different	different	ADJ
aijmsr-196	38	12	study	study	NOUN
aijmsr-196	38	13	groups	group	NOUN
aijmsr-196	38	14	mmp-7	mmp-7	X
aijmsr-196	38	15	,	,	PUNCT
aijmsr-196	38	16	ng	ng	PROPN
aijmsr-196	38	17	/	/	SYM
aijmsr-196	38	18	ml	ml	PROPN
aijmsr-196	38	19	mmp-10	mmp-10	PROPN
aijmsr-196	38	20	,	,	PUNCT
aijmsr-196	38	21	ng	ng	PROPN
aijmsr-196	38	22	/	/	SYM
aijmsr-196	38	23	ml	ml	ADP
aijmsr-196	38	24	healthy	healthy	ADJ
aijmsr-196	38	25	persons	person	NOUN
aijmsr-196	38	26	44.01	44.01	NUM
aijmsr-196	38	27	617.83	617.83	NUM
aijmsr-196	38	28	patients	patient	NOUN
aijmsr-196	38	29	with	with	ADP
aijmsr-196	38	30	arterial	arterial	ADJ
aijmsr-196	38	31	hypertension	hypertension	NOUN
aijmsr-196	38	32	73.08	73.08	NUM
aijmsr-196	38	33	832.37	832.37	NUM
aijmsr-196	38	34	patients	patient	NOUN
aijmsr-196	38	35	with	with	ADP
aijmsr-196	38	36	ckd	ckd	PROPN
aijmsr-196	38	37	41.04	41.04	NUM
aijmsr-196	38	38	871.72	871.72	NUM
aijmsr-196	38	39	patients	patient	NOUN
aijmsr-196	38	40	with	with	ADP
aijmsr-196	38	41	end	end	NOUN
aijmsr-196	38	42	-	-	PUNCT
aijmsr-196	38	43	stage	stage	NOUN
aijmsr-196	38	44	ckd	ckd	NOUN
aijmsr-196	38	45	on	on	ADP
aijmsr-196	38	46	chroniodialysis	chroniodialysis	NOUN
aijmsr-196	38	47	69.44	69.44	NUM
aijmsr-196	38	48	2452.35	2452.35	NUM
aijmsr-196	38	49	we	we	PRON
aijmsr-196	38	50	found	find	VERB
aijmsr-196	38	51	approximately	approximately	ADV
aijmsr-196	38	52	1.5	1.5	NUM
aijmsr-196	38	53	-	-	NUM
aijmsr-196	38	54	fold	fold	ADJ
aijmsr-196	38	55	higher	high	ADJ
aijmsr-196	38	56	mean	mean	NOUN
aijmsr-196	38	57	serum	serum	NOUN
aijmsr-196	38	58	level	level	NOUN
aijmsr-196	38	59	of	of	ADP
aijmsr-196	38	60	mmp-7	mmp-7	NUM
aijmsr-196	38	61	among	among	ADP
aijmsr-196	38	62	patients	patient	NOUN
aijmsr-196	38	63	with	with	ADP
aijmsr-196	38	64	isolated	isolated	ADJ
aijmsr-196	38	65	arterial	arterial	ADJ
aijmsr-196	38	66	hypertension	hypertension	NOUN
aijmsr-196	38	67	and	and	CCONJ
aijmsr-196	38	68	ckd	ckd	NOUN
aijmsr-196	38	69	patients	patient	NOUN
aijmsr-196	38	70	on	on	ADP
aijmsr-196	38	71	dialysis	dialysis	NOUN
aijmsr-196	38	72	than	than	ADP
aijmsr-196	38	73	those	those	PRON
aijmsr-196	38	74	on	on	ADP
aijmsr-196	38	75	stages	stage	NOUN
aijmsr-196	38	76	i	i	PROPN
aijmsr-196	38	77	–	–	PUNCT
aijmsr-196	38	78	iii	iii	NUM
aijmsr-196	38	79	ckd	ckd	PROPN
aijmsr-196	38	80	and	and	CCONJ
aijmsr-196	38	81	then	then	ADV
aijmsr-196	38	82	healthy	healthy	ADJ
aijmsr-196	38	83	persons	person	NOUN
aijmsr-196	38	84	(	(	PUNCT
aijmsr-196	38	85	figure	figure	NOUN
aijmsr-196	38	86	1	1	NUM
aijmsr-196	38	87	)	)	PUNCT
aijmsr-196	38	88	.	.	PUNCT
aijmsr-196	39	1	ckd	ckd	PROPN
aijmsr-196	39	2	patients	patient	NOUN
aijmsr-196	39	3	on	on	ADP
aijmsr-196	39	4	chroniodialysis	chroniodialysis	NOUN
aijmsr-196	39	5	exhibited	exhibit	VERB
aijmsr-196	39	6	significantly	significantly	ADV
aijmsr-196	39	7	much	much	ADV
aijmsr-196	39	8	higher	high	ADJ
aijmsr-196	39	9	concentration	concentration	NOUN
aijmsr-196	39	10	of	of	ADP
aijmsr-196	39	11	mmp-10	mmp-10	NUM
aijmsr-196	39	12	than	than	ADP
aijmsr-196	39	13	healthy	healthy	ADJ
aijmsr-196	39	14	persons	person	NOUN
aijmsr-196	39	15	(	(	PUNCT
aijmsr-196	39	16	p	p	X
aijmsr-196	39	17	<	<	X
aijmsr-196	39	18	0.001	0.001	NUM
aijmsr-196	39	19	)	)	PUNCT
aijmsr-196	39	20	,	,	PUNCT
aijmsr-196	39	21	than	than	ADP
aijmsr-196	39	22	patients	patient	NOUN
aijmsr-196	39	23	with	with	ADP
aijmsr-196	39	24	isolated	isolated	ADJ
aijmsr-196	39	25	arterial	arterial	ADJ
aijmsr-196	39	26	hypertension	hypertension	NOUN
aijmsr-196	39	27	(	(	PUNCT
aijmsr-196	39	28	p	p	X
aijmsr-196	39	29	<	<	X
aijmsr-196	39	30	0.001	0.001	NUM
aijmsr-196	39	31	)	)	PUNCT
aijmsr-196	39	32	and	and	CCONJ
aijmsr-196	39	33	patients	patient	NOUN
aijmsr-196	39	34	at	at	ADP
aijmsr-196	39	35	different	different	ADJ
aijmsr-196	39	36	stages	stage	NOUN
aijmsr-196	39	37	of	of	ADP
aijmsr-196	39	38	ckd	ckd	PROPN
aijmsr-196	39	39	(	(	PUNCT
aijmsr-196	39	40	p	p	NOUN
aijmsr-196	39	41	=	=	NOUN
aijmsr-196	39	42	0.037	0.037	NUM
aijmsr-196	39	43	)	)	PUNCT
aijmsr-196	39	44	(	(	PUNCT
aijmsr-196	39	45	figure	figure	NOUN
aijmsr-196	39	46	2	2	NUM
aijmsr-196	39	47	)	)	PUNCT
aijmsr-196	39	48	.	.	PUNCT
aijmsr-196	40	1	copyright	copyright	NOUN
aijmsr-196	40	2	©	©	PROPN
aijmsr-196	40	3	cc	cc	PROPN
aijmsr-196	40	4	-	-	PUNCT
aijmsr-196	40	5	by	by	ADP
aijmsr-196	40	6	-	-	PUNCT
aijmsr-196	40	7	nc	nc	PROPN
aijmsr-196	40	8	2018	2018	NUM
aijmsr-196	40	9	,	,	PUNCT
aijmsr-196	40	10	cribfb	cribfb	VERB
aijmsr-196	40	11	|	|	CCONJ
aijmsr-196	40	12	aijmsr	aijmsr	NOUN
aijmsr-196	40	13	www.cribfb.com/journal/index.php/aijmsr	www.cribfb.com/journal/index.php/aijmsr	VERB
aijmsr-196	40	14	american	american	PROPN
aijmsr-196	40	15	international	international	PROPN
aijmsr-196	40	16	journal	journal	PROPN
aijmsr-196	40	17	of	of	ADP
aijmsr-196	40	18	multidisciplinary	multidisciplinary	ADJ
aijmsr-196	40	19	scientific	scientific	ADJ
aijmsr-196	40	20	research	research	NOUN
aijmsr-196	40	21	vol	vol	NOUN
aijmsr-196	40	22	.	.	PROPN
aijmsr-196	41	1	4	4	NUM
aijmsr-196	41	2	,	,	PUNCT
aijmsr-196	41	3	no	no	INTJ
aijmsr-196	41	4	.	.	NOUN
aijmsr-196	41	5	1	1	NUM
aijmsr-196	41	6	;	;	PUNCT
aijmsr-196	41	7	2018	2018	NUM
aijmsr-196	41	8	19	19	NUM
aijmsr-196	41	9	figure	figure	NOUN
aijmsr-196	41	10	1	1	NUM
aijmsr-196	41	11	.	.	PUNCT
aijmsr-196	41	12	differences	difference	NOUN
aijmsr-196	41	13	in	in	ADP
aijmsr-196	41	14	serum	serum	NOUN
aijmsr-196	41	15	levels	level	NOUN
aijmsr-196	41	16	of	of	ADP
aijmsr-196	41	17	matrix	matrix	NOUN
aijmsr-196	41	18	metalloproteinases	metalloproteinase	VERB
aijmsr-196	41	19	7	7	NUM
aijmsr-196	41	20	in	in	ADP
aijmsr-196	41	21	the	the	DET
aijmsr-196	41	22	study	study	NOUN
aijmsr-196	41	23	groups	group	NOUN
aijmsr-196	41	24	figure	figure	VERB
aijmsr-196	41	25	2	2	NUM
aijmsr-196	41	26	.	.	PUNCT
aijmsr-196	41	27	differences	difference	NOUN
aijmsr-196	41	28	in	in	ADP
aijmsr-196	41	29	serum	serum	NOUN
aijmsr-196	41	30	levels	level	NOUN
aijmsr-196	41	31	of	of	ADP
aijmsr-196	41	32	matrix	matrix	NOUN
aijmsr-196	41	33	metalloproteinases	metalloproteinase	VERB
aijmsr-196	41	34	10	10	NUM
aijmsr-196	41	35	in	in	ADP
aijmsr-196	41	36	the	the	DET
aijmsr-196	41	37	study	study	NOUN
aijmsr-196	41	38	groups	group	NOUN
aijmsr-196	41	39	detected	detect	VERB
aijmsr-196	41	40	serum	serum	NOUN
aijmsr-196	41	41	levels	level	NOUN
aijmsr-196	41	42	of	of	ADP
aijmsr-196	41	43	mmp-10	mmp-10	NUM
aijmsr-196	41	44	were	be	AUX
aijmsr-196	41	45	higher	high	ADJ
aijmsr-196	41	46	compared	compare	VERB
aijmsr-196	41	47	to	to	ADP
aijmsr-196	41	48	the	the	DET
aijmsr-196	41	49	levels	level	NOUN
aijmsr-196	41	50	of	of	ADP
aijmsr-196	41	51	mmp-7	mmp-7	PRON
aijmsr-196	41	52	(	(	PUNCT
aijmsr-196	41	53	table	table	NOUN
aijmsr-196	41	54	1	1	NUM
aijmsr-196	41	55	)	)	PUNCT
aijmsr-196	41	56	.	.	PUNCT
aijmsr-196	42	1	the	the	DET
aijmsr-196	42	2	correlation	correlation	NOUN
aijmsr-196	42	3	between	between	ADP
aijmsr-196	42	4	two	two	NUM
aijmsr-196	42	5	parameters	parameter	NOUN
aijmsr-196	42	6	did	do	AUX
aijmsr-196	42	7	not	not	PART
aijmsr-196	42	8	reach	reach	VERB
aijmsr-196	42	9	significance	significance	NOUN
aijmsr-196	42	10	(	(	PUNCT
aijmsr-196	42	11	p	p	X
aijmsr-196	42	12	=	=	NOUN
aijmsr-196	42	13	0.081	0.081	NUM
aijmsr-196	42	14	)	)	PUNCT
aijmsr-196	42	15	.	.	PUNCT
aijmsr-196	43	1	4	4	X
aijmsr-196	43	2	.	.	X
aijmsr-196	43	3	discussion	discussion	NOUN
aijmsr-196	43	4	among	among	ADP
aijmsr-196	43	5	different	different	ADJ
aijmsr-196	43	6	mmps	mmp	NOUN
aijmsr-196	43	7	,	,	PUNCT
aijmsr-196	43	8	we	we	PRON
aijmsr-196	43	9	have	have	AUX
aijmsr-196	43	10	paid	pay	VERB
aijmsr-196	43	11	particular	particular	ADJ
aijmsr-196	43	12	attention	attention	NOUN
aijmsr-196	43	13	to	to	ADP
aijmsr-196	43	14	two	two	NUM
aijmsr-196	43	15	of	of	ADP
aijmsr-196	43	16	them	they	PRON
aijmsr-196	43	17	mmp-7	mmp-7	PRON
aijmsr-196	43	18	and	and	CCONJ
aijmsr-196	43	19	mmp-10	mmp-10	PRON
aijmsr-196	43	20	which	which	PRON
aijmsr-196	43	21	are	be	AUX
aijmsr-196	43	22	thought	think	VERB
aijmsr-196	43	23	to	to	PART
aijmsr-196	43	24	be	be	AUX
aijmsr-196	43	25	involved	involve	VERB
aijmsr-196	43	26	in	in	ADP
aijmsr-196	43	27	ckd	ckd	PROPN
aijmsr-196	43	28	pathogenesis	pathogenesis	PROPN
aijmsr-196	43	29	.	.	PUNCT
aijmsr-196	44	1	mmp-7	mmp-7	X
aijmsr-196	44	2	levels	level	NOUN
aijmsr-196	44	3	were	be	AUX
aijmsr-196	44	4	increased	increase	VERB
aijmsr-196	44	5	in	in	ADP
aijmsr-196	44	6	the	the	DET
aijmsr-196	44	7	group	group	NOUN
aijmsr-196	44	8	of	of	ADP
aijmsr-196	44	9	dialysis	dialysis	NOUN
aijmsr-196	44	10	patients	patient	NOUN
aijmsr-196	44	11	when	when	SCONJ
aijmsr-196	44	12	compared	compare	VERB
aijmsr-196	44	13	with	with	ADP
aijmsr-196	44	14	the	the	DET
aijmsr-196	44	15	other	other	ADJ
aijmsr-196	44	16	ckd	ckd	PROPN
aijmsr-196	44	17	group	group	NOUN
aijmsr-196	44	18	and	and	CCONJ
aijmsr-196	44	19	healthy	healthy	ADJ
aijmsr-196	44	20	persons	person	NOUN
aijmsr-196	44	21	(	(	PUNCT
aijmsr-196	44	22	figure	figure	NOUN
aijmsr-196	44	23	1	1	NUM
aijmsr-196	44	24	)	)	PUNCT
aijmsr-196	44	25	.	.	PUNCT
aijmsr-196	45	1	some	some	DET
aijmsr-196	45	2	studies	study	NOUN
aijmsr-196	45	3	on	on	ADP
aijmsr-196	45	4	animal	animal	NOUN
aijmsr-196	45	5	models	model	NOUN
aijmsr-196	45	6	of	of	ADP
aijmsr-196	45	7	experimental	experimental	ADJ
aijmsr-196	45	8	renal	renal	ADJ
aijmsr-196	45	9	tubular	tubular	ADJ
aijmsr-196	45	10	injury	injury	NOUN
aijmsr-196	45	11	showed	show	VERB
aijmsr-196	45	12	that	that	SCONJ
aijmsr-196	45	13	mmp-7	mmp-7	PRON
aijmsr-196	45	14	was	be	AUX
aijmsr-196	45	15	expressed	express	VERB
aijmsr-196	45	16	in	in	ADP
aijmsr-196	45	17	response	response	NOUN
aijmsr-196	45	18	to	to	ADP
aijmsr-196	45	19	injury	injury	NOUN
aijmsr-196	45	20	in	in	ADP
aijmsr-196	45	21	the	the	DET
aijmsr-196	45	22	distal	distal	ADJ
aijmsr-196	45	23	nephron	nephron	NOUN
aijmsr-196	45	24	.	.	PUNCT
aijmsr-196	46	1	moreover	moreover	ADV
aijmsr-196	46	2	,	,	PUNCT
aijmsr-196	46	3	surendran	surendran	NOUN
aijmsr-196	46	4	et	et	PROPN
aijmsr-196	46	5	al	al	PROPN
aijmsr-196	46	6	.	.	PROPN
aijmsr-196	46	7	found	find	VERB
aijmsr-196	46	8	a	a	DET
aijmsr-196	46	9	correlation	correlation	NOUN
aijmsr-196	46	10	between	between	ADP
aijmsr-196	46	11	mmp-7	mmp-7	DET
aijmsr-196	46	12	expression	expression	NOUN
aijmsr-196	46	13	in	in	ADP
aijmsr-196	46	14	human	human	ADJ
aijmsr-196	46	15	kidney	kidney	NOUN
aijmsr-196	46	16	diseases	disease	NOUN
aijmsr-196	46	17	and	and	CCONJ
aijmsr-196	46	18	chronic	chronic	ADJ
aijmsr-196	46	19	renal	renal	ADJ
aijmsr-196	46	20	tubular	tubular	ADJ
aijmsr-196	46	21	damage	damage	NOUN
aijmsr-196	46	22	due	due	ADP
aijmsr-196	46	23	to	to	ADP
aijmsr-196	46	24	fibrosis	fibrosis	NOUN
aijmsr-196	46	25	where	where	SCONJ
aijmsr-196	46	26	mrna	mrna	PROPN
aijmsr-196	46	27	level	level	NOUN
aijmsr-196	46	28	of	of	ADP
aijmsr-196	46	29	matrilysin	matrilysin	NOUN
aijmsr-196	46	30	was	be	AUX
aijmsr-196	46	31	increased	increase	VERB
aijmsr-196	46	32	as	as	SCONJ
aijmsr-196	46	33	renal	renal	ADJ
aijmsr-196	46	34	fibrosis	fibrosis	NOUN
aijmsr-196	46	35	progressed	progress	VERB
aijmsr-196	46	36	.	.	PUNCT
aijmsr-196	46	37	8	8	NUM
aijmsr-196	46	38	on	on	ADP
aijmsr-196	46	39	that	that	DET
aijmsr-196	46	40	basis	basis	NOUN
aijmsr-196	46	41	,	,	PUNCT
aijmsr-196	46	42	we	we	PRON
aijmsr-196	46	43	can	can	AUX
aijmsr-196	46	44	speculate	speculate	VERB
aijmsr-196	46	45	that	that	SCONJ
aijmsr-196	46	46	the	the	DET
aijmsr-196	46	47	increased	increase	VERB
aijmsr-196	46	48	level	level	NOUN
aijmsr-196	46	49	of	of	ADP
aijmsr-196	46	50	mmp-7	mmp-7	PUNCT
aijmsr-196	46	51	may	may	AUX
aijmsr-196	46	52	point	point	VERB
aijmsr-196	46	53	out	out	ADP
aijmsr-196	46	54	the	the	DET
aijmsr-196	46	55	development	development	NOUN
aijmsr-196	46	56	of	of	ADP
aijmsr-196	46	57	fibrosis	fibrosis	NOUN
aijmsr-196	46	58	and	and	CCONJ
aijmsr-196	46	59	could	could	AUX
aijmsr-196	46	60	be	be	AUX
aijmsr-196	46	61	a	a	DET
aijmsr-196	46	62	potential	potential	ADJ
aijmsr-196	46	63	biomarker	biomarker	NOUN
aijmsr-196	46	64	for	for	ADP
aijmsr-196	46	65	fibrotic	fibrotic	ADJ
aijmsr-196	46	66	complications	complication	NOUN
aijmsr-196	46	67	in	in	ADP
aijmsr-196	46	68	ckd	ckd	PROPN
aijmsr-196	46	69	.	.	PUNCT
aijmsr-196	47	1	these	these	DET
aijmsr-196	47	2	hypotheses	hypothesis	NOUN
aijmsr-196	47	3	are	be	AUX
aijmsr-196	47	4	based	base	VERB
aijmsr-196	47	5	on	on	ADP
aijmsr-196	47	6	the	the	DET
aijmsr-196	47	7	presumption	presumption	NOUN
aijmsr-196	47	8	that	that	SCONJ
aijmsr-196	47	9	serum	serum	NOUN
aijmsr-196	47	10	levels	level	NOUN
aijmsr-196	47	11	of	of	ADP
aijmsr-196	47	12	mmp-7	mmp-7	PUNCT
aijmsr-196	47	13	represent	represent	VERB
aijmsr-196	47	14	its	its	PRON
aijmsr-196	47	15	protein	protein	NOUN
aijmsr-196	47	16	expression	expression	NOUN
aijmsr-196	47	17	0	0	NUM
aijmsr-196	47	18	10	10	NUM
aijmsr-196	47	19	20	20	NUM
aijmsr-196	47	20	30	30	NUM
aijmsr-196	47	21	40	40	NUM
aijmsr-196	47	22	50	50	NUM
aijmsr-196	47	23	60	60	NUM
aijmsr-196	47	24	70	70	NUM
aijmsr-196	47	25	80	80	NUM
aijmsr-196	47	26	90	90	NUM
aijmsr-196	47	27	healthy	healthy	ADJ
aijmsr-196	47	28	persons	person	NOUN
aijmsr-196	47	29	patients	patient	NOUN
aijmsr-196	47	30	with	with	ADP
aijmsr-196	47	31	arterial	arterial	ADJ
aijmsr-196	47	32	hypertension	hypertension	NOUN
aijmsr-196	47	33	patients	patient	NOUN
aijmsr-196	47	34	with	with	ADP
aijmsr-196	47	35	chronic	chronic	ADJ
aijmsr-196	47	36	kidney	kidney	NOUN
aijmsr-196	47	37	disease	disease	NOUN
aijmsr-196	47	38	patients	patient	NOUN
aijmsr-196	47	39	with	with	ADP
aijmsr-196	47	40	chronic	chronic	ADJ
aijmsr-196	47	41	kidney	kidney	NOUN
aijmsr-196	47	42	disease	disease	NOUN
aijmsr-196	47	43	on	on	ADP
aijmsr-196	47	44	chroniodialysis	chroniodialysis	NOUN
aijmsr-196	47	45	n	n	PRON
aijmsr-196	47	46	g	g	NOUN
aijmsr-196	47	47	/m	/m	PUNCT
aijmsr-196	48	1	l	l	NOUN
aijmsr-196	48	2	0	0	NUM
aijmsr-196	48	3	500	500	NUM
aijmsr-196	48	4	1000	1000	NUM
aijmsr-196	48	5	1500	1500	NUM
aijmsr-196	48	6	2000	2000	NUM
aijmsr-196	48	7	2500	2500	NUM
aijmsr-196	48	8	3000	3000	NUM
aijmsr-196	48	9	3500	3500	NUM
aijmsr-196	48	10	healthy	healthy	ADJ
aijmsr-196	48	11	persons	person	NOUN
aijmsr-196	48	12	patients	patient	NOUN
aijmsr-196	48	13	with	with	ADP
aijmsr-196	48	14	arterial	arterial	ADJ
aijmsr-196	48	15	hypertension	hypertension	NOUN
aijmsr-196	48	16	patients	patient	NOUN
aijmsr-196	48	17	with	with	ADP
aijmsr-196	48	18	chronic	chronic	ADJ
aijmsr-196	48	19	kidney	kidney	NOUN
aijmsr-196	48	20	disease	disease	NOUN
aijmsr-196	48	21	patients	patient	NOUN
aijmsr-196	48	22	with	with	ADP
aijmsr-196	48	23	chronic	chronic	ADJ
aijmsr-196	48	24	kidney	kidney	NOUN
aijmsr-196	48	25	disease	disease	NOUN
aijmsr-196	48	26	on	on	ADP
aijmsr-196	48	27	chroniodialysis	chroniodialysis	NOUN
aijmsr-196	48	28	n	n	PRON
aijmsr-196	48	29	g	g	NOUN
aijmsr-196	48	30	/m	/m	PUNCT
aijmsr-196	49	1	l	l	PUNCT
aijmsr-196	50	1	p	p	X
aijmsr-196	50	2	<	<	X
aijmsr-196	50	3	0.001	0.001	NUM
aijmsr-196	50	4	p	p	NOUN
aijmsr-196	50	5	=	=	NOUN
aijmsr-196	50	6	0.000	0.000	NUM
aijmsr-196	50	7	p	p	NOUN
aijmsr-196	50	8	=	=	NOUN
aijmsr-196	50	9	0.037	0.037	NUM
aijmsr-196	50	10	copyright	copyright	NOUN
aijmsr-196	50	11	©	©	PROPN
aijmsr-196	50	12	cc	cc	PROPN
aijmsr-196	50	13	-	-	PUNCT
aijmsr-196	50	14	by	by	ADP
aijmsr-196	50	15	-	-	PUNCT
aijmsr-196	50	16	nc	nc	PROPN
aijmsr-196	50	17	2018	2018	NUM
aijmsr-196	50	18	,	,	PUNCT
aijmsr-196	50	19	cribfb	cribfb	VERB
aijmsr-196	50	20	|	|	CCONJ
aijmsr-196	50	21	aijmsr	aijmsr	NOUN
aijmsr-196	50	22	www.cribfb.com/journal/index.php/aijmsr	www.cribfb.com/journal/index.php/aijmsr	VERB
aijmsr-196	50	23	american	american	PROPN
aijmsr-196	50	24	international	international	PROPN
aijmsr-196	50	25	journal	journal	PROPN
aijmsr-196	50	26	of	of	ADP
aijmsr-196	50	27	multidisciplinary	multidisciplinary	ADJ
aijmsr-196	50	28	scientific	scientific	ADJ
aijmsr-196	50	29	research	research	NOUN
aijmsr-196	50	30	vol	vol	NOUN
aijmsr-196	50	31	.	.	PROPN
aijmsr-196	51	1	4	4	NUM
aijmsr-196	51	2	,	,	PUNCT
aijmsr-196	51	3	no	no	INTJ
aijmsr-196	51	4	.	.	NOUN
aijmsr-196	51	5	1	1	NUM
aijmsr-196	51	6	;	;	PUNCT
aijmsr-196	51	7	2018	2018	NUM
aijmsr-196	51	8	20	20	NUM
aijmsr-196	51	9	in	in	ADP
aijmsr-196	51	10	the	the	DET
aijmsr-196	51	11	injured	injure	VERB
aijmsr-196	51	12	kidneys	kidney	NOUN
aijmsr-196	51	13	.	.	PUNCT
aijmsr-196	52	1	however	however	ADV
aijmsr-196	52	2	,	,	PUNCT
aijmsr-196	52	3	it	it	PRON
aijmsr-196	52	4	is	be	AUX
aijmsr-196	52	5	well	well	ADV
aijmsr-196	52	6	known	know	VERB
aijmsr-196	52	7	that	that	SCONJ
aijmsr-196	52	8	in	in	ADP
aijmsr-196	52	9	some	some	DET
aijmsr-196	52	10	circumstances	circumstance	NOUN
aijmsr-196	52	11	the	the	DET
aijmsr-196	52	12	systemic	systemic	ADJ
aijmsr-196	52	13	protein	protein	NOUN
aijmsr-196	52	14	levels	level	NOUN
aijmsr-196	52	15	do	do	AUX
aijmsr-196	52	16	not	not	PART
aijmsr-196	52	17	mirror	mirror	VERB
aijmsr-196	52	18	the	the	DET
aijmsr-196	52	19	local	local	ADJ
aijmsr-196	52	20	production	production	NOUN
aijmsr-196	52	21	of	of	ADP
aijmsr-196	52	22	specific	specific	ADJ
aijmsr-196	52	23	proteins	protein	NOUN
aijmsr-196	52	24	.	.	PUNCT
aijmsr-196	53	1	the	the	DET
aijmsr-196	53	2	lack	lack	NOUN
aijmsr-196	53	3	of	of	ADP
aijmsr-196	53	4	mmp-7	mmp-7	DET
aijmsr-196	53	5	expression	expression	NOUN
aijmsr-196	53	6	in	in	ADP
aijmsr-196	53	7	healthy	healthy	ADJ
aijmsr-196	53	8	kidneys	kidney	NOUN
aijmsr-196	53	9	in	in	ADP
aijmsr-196	53	10	humans	human	NOUN
aijmsr-196	53	11	and	and	CCONJ
aijmsr-196	53	12	mice	mouse	NOUN
aijmsr-196	53	13	8	8	NUM
aijmsr-196	53	14	is	be	AUX
aijmsr-196	53	15	in	in	ADP
aijmsr-196	53	16	consistent	consistent	ADJ
aijmsr-196	53	17	with	with	ADP
aijmsr-196	53	18	our	our	PRON
aijmsr-196	53	19	findings	finding	NOUN
aijmsr-196	53	20	for	for	ADP
aijmsr-196	53	21	a	a	DET
aijmsr-196	53	22	lower	low	ADJ
aijmsr-196	53	23	level	level	NOUN
aijmsr-196	53	24	of	of	ADP
aijmsr-196	53	25	mmp-7	mmp-7	NUM
aijmsr-196	53	26	in	in	ADP
aijmsr-196	53	27	the	the	DET
aijmsr-196	53	28	control	control	NOUN
aijmsr-196	53	29	group	group	NOUN
aijmsr-196	53	30	of	of	ADP
aijmsr-196	53	31	healthy	healthy	ADJ
aijmsr-196	53	32	persons	person	NOUN
aijmsr-196	53	33	.	.	PUNCT
aijmsr-196	54	1	similarly	similarly	ADV
aijmsr-196	54	2	,	,	PUNCT
aijmsr-196	54	3	mmp-7	mmp-7	DET
aijmsr-196	54	4	concentrations	concentration	NOUN
aijmsr-196	54	5	were	be	AUX
aijmsr-196	54	6	higher	high	ADJ
aijmsr-196	54	7	in	in	ADP
aijmsr-196	54	8	patients	patient	NOUN
aijmsr-196	54	9	from	from	ADP
aijmsr-196	54	10	the	the	DET
aijmsr-196	54	11	control	control	NOUN
aijmsr-196	54	12	group	group	NOUN
aijmsr-196	54	13	with	with	ADP
aijmsr-196	54	14	isolated	isolate	VERB
aijmsr-196	54	15	arterial	arterial	ADJ
aijmsr-196	54	16	hypertension	hypertension	NOUN
aijmsr-196	54	17	than	than	ADP
aijmsr-196	54	18	in	in	ADP
aijmsr-196	54	19	the	the	DET
aijmsr-196	54	20	healthy	healthy	ADJ
aijmsr-196	54	21	persons	person	NOUN
aijmsr-196	54	22	.	.	PUNCT
aijmsr-196	55	1	however	however	ADV
aijmsr-196	55	2	,	,	PUNCT
aijmsr-196	55	3	these	these	DET
aijmsr-196	55	4	observations	observation	NOUN
aijmsr-196	55	5	also	also	ADV
aijmsr-196	55	6	did	do	AUX
aijmsr-196	55	7	not	not	PART
aijmsr-196	55	8	reach	reach	VERB
aijmsr-196	55	9	statistical	statistical	ADJ
aijmsr-196	55	10	significance	significance	NOUN
aijmsr-196	55	11	.	.	PUNCT
aijmsr-196	56	1	the	the	DET
aijmsr-196	56	2	concentration	concentration	NOUN
aijmsr-196	56	3	of	of	ADP
aijmsr-196	56	4	mmp-10	mmp-10	PROPN
aijmsr-196	56	5	was	be	AUX
aijmsr-196	56	6	significantly	significantly	ADV
aijmsr-196	56	7	higher	high	ADJ
aijmsr-196	56	8	in	in	ADP
aijmsr-196	56	9	the	the	DET
aijmsr-196	56	10	dialysis	dialysis	NOUN
aijmsr-196	56	11	ckd	ckd	PROPN
aijmsr-196	56	12	patients	patient	NOUN
aijmsr-196	56	13	group	group	NOUN
aijmsr-196	56	14	than	than	ADP
aijmsr-196	56	15	in	in	ADP
aijmsr-196	56	16	the	the	DET
aijmsr-196	56	17	other	other	ADJ
aijmsr-196	56	18	three	three	NUM
aijmsr-196	56	19	groups	group	NOUN
aijmsr-196	56	20	(	(	PUNCT
aijmsr-196	56	21	figure	figure	NOUN
aijmsr-196	56	22	2	2	NUM
aijmsr-196	56	23	)	)	PUNCT
aijmsr-196	56	24	.	.	PUNCT
aijmsr-196	57	1	a	a	DET
aijmsr-196	57	2	cross	cross	ADJ
aijmsr-196	57	3	-	-	ADJ
aijmsr-196	57	4	sectional	sectional	ADJ
aijmsr-196	57	5	study	study	NOUN
aijmsr-196	57	6	of	of	ADP
aijmsr-196	57	7	belal	belal	PROPN
aijmsr-196	57	8	et	et	PROPN
aijmsr-196	57	9	al	al	PROPN
aijmsr-196	57	10	.	.	PROPN
aijmsr-196	57	11	9	9	NUM
aijmsr-196	57	12	with	with	ADP
aijmsr-196	57	13	40	40	NUM
aijmsr-196	57	14	patients	patient	NOUN
aijmsr-196	57	15	of	of	ADP
aijmsr-196	57	16	ckd	ckd	PROPN
aijmsr-196	57	17	showed	show	VERB
aijmsr-196	57	18	that	that	SCONJ
aijmsr-196	57	19	serum	serum	NOUN
aijmsr-196	57	20	level	level	NOUN
aijmsr-196	57	21	of	of	ADP
aijmsr-196	57	22	mmp-10	mmp-10	PRON
aijmsr-196	57	23	measured	measure	VERB
aijmsr-196	57	24	by	by	ADP
aijmsr-196	57	25	elisa	elisa	PROPN
aijmsr-196	57	26	was	be	AUX
aijmsr-196	57	27	at	at	ADP
aijmsr-196	57	28	mean	mean	ADJ
aijmsr-196	57	29	concentration	concentration	NOUN
aijmsr-196	57	30	of	of	ADP
aijmsr-196	57	31	601	601	NUM
aijmsr-196	57	32	±	±	NUM
aijmsr-196	57	33	132.12	132.12	NUM
aijmsr-196	57	34	pg	pg	PROPN
aijmsr-196	57	35	/	/	SYM
aijmsr-196	57	36	dl	dl	PROPN
aijmsr-196	57	37	in	in	ADP
aijmsr-196	57	38	the	the	DET
aijmsr-196	57	39	control	control	NOUN
aijmsr-196	57	40	group	group	NOUN
aijmsr-196	57	41	whereas	whereas	SCONJ
aijmsr-196	57	42	the	the	DET
aijmsr-196	57	43	mean	mean	ADJ
aijmsr-196	57	44	level	level	NOUN
aijmsr-196	57	45	in	in	ADP
aijmsr-196	57	46	patients	patient	NOUN
aijmsr-196	57	47	on	on	ADP
aijmsr-196	57	48	dialysis	dialysis	NOUN
aijmsr-196	57	49	group	group	NOUN
aijmsr-196	57	50	was	be	AUX
aijmsr-196	57	51	2306.45	2306.45	NUM
aijmsr-196	57	52	±	±	NUM
aijmsr-196	57	53	335.247	335.247	NUM
aijmsr-196	57	54	pg	pg	PROPN
aijmsr-196	57	55	/	/	SYM
aijmsr-196	57	56	dl	dl	PROPN
aijmsr-196	57	57	,	,	PUNCT
aijmsr-196	57	58	results	result	NOUN
aijmsr-196	57	59	which	which	PRON
aijmsr-196	57	60	are	be	AUX
aijmsr-196	57	61	similar	similar	ADJ
aijmsr-196	57	62	to	to	ADP
aijmsr-196	57	63	our	our	PRON
aijmsr-196	57	64	findings	finding	NOUN
aijmsr-196	57	65	.	.	PUNCT
aijmsr-196	58	1	they	they	PRON
aijmsr-196	58	2	observed	observe	VERB
aijmsr-196	58	3	the	the	DET
aijmsr-196	58	4	mean	mean	ADJ
aijmsr-196	58	5	level	level	NOUN
aijmsr-196	58	6	of	of	ADP
aijmsr-196	58	7	mmp-10	mmp-10	NOUN
aijmsr-196	58	8	in	in	ADP
aijmsr-196	58	9	patients	patient	NOUN
aijmsr-196	58	10	at	at	ADP
aijmsr-196	58	11	earlier	early	ADJ
aijmsr-196	58	12	stages	stage	NOUN
aijmsr-196	58	13	of	of	ADP
aijmsr-196	58	14	ckd	ckd	PROPN
aijmsr-196	58	15	1857.45	1857.45	NUM
aijmsr-196	58	16	±	±	NUM
aijmsr-196	58	17	387.1	387.1	NUM
aijmsr-196	58	18	pg	pg	NOUN
aijmsr-196	58	19	/	/	SYM
aijmsr-196	58	20	dl	dl	PROPN
aijmsr-196	58	21	which	which	PRON
aijmsr-196	58	22	is	be	AUX
aijmsr-196	58	23	about	about	ADV
aijmsr-196	58	24	2times	2times	NUM
aijmsr-196	58	25	higher	high	ADJ
aijmsr-196	58	26	than	than	ADP
aijmsr-196	58	27	our	our	PRON
aijmsr-196	58	28	group	group	NOUN
aijmsr-196	58	29	of	of	ADP
aijmsr-196	58	30	ckd	ckd	PROPN
aijmsr-196	58	31	patients	patient	NOUN
aijmsr-196	58	32	at	at	ADP
aijmsr-196	58	33	ii	ii	PROPN
aijmsr-196	58	34	-	-	PUNCT
aijmsr-196	58	35	iv	iv	NUM
aijmsr-196	58	36	stages	stage	NOUN
aijmsr-196	58	37	.	.	PUNCT
aijmsr-196	59	1	9	9	NUM
aijmsr-196	59	2	the	the	DET
aijmsr-196	59	3	difference	difference	NOUN
aijmsr-196	59	4	between	between	ADP
aijmsr-196	59	5	all	all	DET
aijmsr-196	59	6	three	three	NUM
aijmsr-196	59	7	groups	group	NOUN
aijmsr-196	59	8	has	have	AUX
aijmsr-196	59	9	been	be	AUX
aijmsr-196	59	10	statistically	statistically	ADV
aijmsr-196	59	11	significant	significant	ADJ
aijmsr-196	59	12	(	(	PUNCT
aijmsr-196	59	13	p<0.001	p<0.001	X
aijmsr-196	59	14	)	)	PUNCT
aijmsr-196	59	15	whereas	whereas	SCONJ
aijmsr-196	59	16	in	in	ADP
aijmsr-196	59	17	our	our	PRON
aijmsr-196	59	18	study	study	NOUN
aijmsr-196	59	19	the	the	DET
aijmsr-196	59	20	highest	high	ADJ
aijmsr-196	59	21	level	level	NOUN
aijmsr-196	59	22	of	of	ADP
aijmsr-196	59	23	mmp-10	mmp-10	NUM
aijmsr-196	59	24	was	be	AUX
aijmsr-196	59	25	measured	measure	VERB
aijmsr-196	59	26	in	in	ADP
aijmsr-196	59	27	ckd	ckd	PROPN
aijmsr-196	59	28	on	on	ADP
aijmsr-196	59	29	chroniodialysis	chroniodialysis	NOUN
aijmsr-196	59	30	,	,	PUNCT
aijmsr-196	59	31	and	and	CCONJ
aijmsr-196	59	32	the	the	DET
aijmsr-196	59	33	levels	level	NOUN
aijmsr-196	59	34	in	in	ADP
aijmsr-196	59	35	control	control	NOUN
aijmsr-196	59	36	groups	group	NOUN
aijmsr-196	59	37	and	and	CCONJ
aijmsr-196	59	38	a	a	DET
aijmsr-196	59	39	group	group	NOUN
aijmsr-196	59	40	of	of	ADP
aijmsr-196	59	41	early	early	ADJ
aijmsr-196	59	42	stages	stage	NOUN
aijmsr-196	59	43	of	of	ADP
aijmsr-196	59	44	ckd	ckd	NOUN
aijmsr-196	59	45	patients	patient	NOUN
aijmsr-196	59	46	were	be	AUX
aijmsr-196	59	47	similar	similar	ADJ
aijmsr-196	59	48	.	.	PUNCT
aijmsr-196	60	1	belal	belal	NOUN
aijmsr-196	60	2	et	et	PROPN
aijmsr-196	60	3	al	al	PROPN
aijmsr-196	60	4	.	.	PROPN
aijmsr-196	60	5	9	9	NUM
aijmsr-196	60	6	also	also	ADV
aijmsr-196	60	7	found	find	VERB
aijmsr-196	60	8	that	that	SCONJ
aijmsr-196	60	9	atherosclerosis	atherosclerosis	NOUN
aijmsr-196	60	10	defined	define	VERB
aijmsr-196	60	11	by	by	ADP
aijmsr-196	60	12	the	the	DET
aijmsr-196	60	13	carotid	carotid	NOUN
aijmsr-196	60	14	intima	intima	ADJ
aijmsr-196	60	15	-	-	PUNCT
aijmsr-196	60	16	media	medium	NOUN
aijmsr-196	60	17	thickness	thickness	NOUN
aijmsr-196	60	18	was	be	AUX
aijmsr-196	60	19	severe	severe	ADJ
aijmsr-196	60	20	in	in	ADP
aijmsr-196	60	21	a	a	DET
aijmsr-196	60	22	group	group	NOUN
aijmsr-196	60	23	on	on	ADP
aijmsr-196	60	24	dialysis	dialysis	NOUN
aijmsr-196	60	25	as	as	ADV
aijmsr-196	60	26	well	well	ADV
aijmsr-196	60	27	as	as	ADP
aijmsr-196	60	28	a	a	DET
aijmsr-196	60	29	significant	significant	ADJ
aijmsr-196	60	30	positive	positive	ADJ
aijmsr-196	60	31	correlation	correlation	NOUN
aijmsr-196	60	32	between	between	ADP
aijmsr-196	60	33	mmp-10	mmp-10	PROPN
aijmsr-196	60	34	and	and	CCONJ
aijmsr-196	60	35	carotid	carotid	VERB
aijmsr-196	60	36	intima	intima	ADJ
aijmsr-196	60	37	-	-	PUNCT
aijmsr-196	60	38	media	media	NOUN
aijmsr-196	60	39	thickness	thickness	NOUN
aijmsr-196	60	40	in	in	ADP
aijmsr-196	60	41	all	all	DET
aijmsr-196	60	42	groups	group	NOUN
aijmsr-196	60	43	.	.	PUNCT
aijmsr-196	61	1	coll	coll	PROPN
aijmsr-196	61	2	et	et	PROPN
aijmsr-196	61	3	al	al	PROPN
aijmsr-196	61	4	.	.	PROPN
aijmsr-196	61	5	also	also	ADV
aijmsr-196	61	6	showed	show	VERB
aijmsr-196	61	7	that	that	SCONJ
aijmsr-196	61	8	among	among	ADP
aijmsr-196	61	9	the	the	DET
aijmsr-196	61	10	patients	patient	NOUN
aijmsr-196	61	11	with	with	ADP
aijmsr-196	61	12	ckd	ckd	PROPN
aijmsr-196	61	13	at	at	ADP
aijmsr-196	61	14	different	different	ADJ
aijmsr-196	61	15	stages	stage	NOUN
aijmsr-196	61	16	atherosclerosis	atherosclerosis	NOUN
aijmsr-196	61	17	comorbidity	comorbidity	NOUN
aijmsr-196	61	18	correlated	correlate	VERB
aijmsr-196	61	19	with	with	ADP
aijmsr-196	61	20	mmp-10	mmp-10	DET
aijmsr-196	61	21	levels	level	NOUN
aijmsr-196	61	22	.	.	PUNCT
aijmsr-196	62	1	10	10	NUM
aijmsr-196	62	2	it	it	PRON
aijmsr-196	62	3	is	be	AUX
aijmsr-196	62	4	well	well	ADV
aijmsr-196	62	5	accepted	accept	VERB
aijmsr-196	62	6	that	that	SCONJ
aijmsr-196	62	7	the	the	DET
aijmsr-196	62	8	underlying	underlie	VERB
aijmsr-196	62	9	cardiovascular	cardiovascular	ADJ
aijmsr-196	62	10	disease	disease	NOUN
aijmsr-196	62	11	in	in	ADP
aijmsr-196	62	12	patients	patient	NOUN
aijmsr-196	62	13	with	with	ADP
aijmsr-196	62	14	even	even	ADV
aijmsr-196	62	15	early	early	ADV
aijmsr-196	62	16	-	-	PUNCT
aijmsr-196	62	17	staged	stage	VERB
aijmsr-196	62	18	ckd	ckd	NOUN
aijmsr-196	62	19	is	be	AUX
aijmsr-196	62	20	one	one	NUM
aijmsr-196	62	21	of	of	ADP
aijmsr-196	62	22	the	the	DET
aijmsr-196	62	23	causes	cause	NOUN
aijmsr-196	62	24	for	for	ADP
aijmsr-196	62	25	increased	increase	VERB
aijmsr-196	62	26	mortality	mortality	NOUN
aijmsr-196	62	27	in	in	ADP
aijmsr-196	62	28	these	these	DET
aijmsr-196	62	29	patients	patient	NOUN
aijmsr-196	62	30	than	than	ADP
aijmsr-196	62	31	in	in	ADP
aijmsr-196	62	32	the	the	DET
aijmsr-196	62	33	general	general	ADJ
aijmsr-196	62	34	population	population	NOUN
aijmsr-196	62	35	.	.	PUNCT
aijmsr-196	63	1	11	11	NUM
aijmsr-196	63	2	mmp-10	mmp-10	PRON
aijmsr-196	63	3	has	have	VERB
aijmsr-196	63	4	alternative	alternative	ADJ
aijmsr-196	63	5	properties	property	NOUN
aijmsr-196	63	6	–	–	PUNCT
aijmsr-196	63	7	on	on	ADP
aijmsr-196	63	8	the	the	DET
aijmsr-196	63	9	one	one	NUM
aijmsr-196	63	10	hand	hand	NOUN
aijmsr-196	63	11	,	,	PUNCT
aijmsr-196	63	12	it	it	PRON
aijmsr-196	63	13	can	can	AUX
aijmsr-196	63	14	contribute	contribute	VERB
aijmsr-196	63	15	to	to	ADP
aijmsr-196	63	16	the	the	DET
aijmsr-196	63	17	pathogenesis	pathogenesis	NOUN
aijmsr-196	63	18	of	of	ADP
aijmsr-196	63	19	atherosclerosis	atherosclerosis	NOUN
aijmsr-196	63	20	by	by	ADP
aijmsr-196	63	21	promoting	promote	VERB
aijmsr-196	63	22	migration	migration	NOUN
aijmsr-196	63	23	and	and	CCONJ
aijmsr-196	63	24	proliferation	proliferation	NOUN
aijmsr-196	63	25	of	of	ADP
aijmsr-196	63	26	vascular	vascular	ADJ
aijmsr-196	63	27	smooth	smooth	ADJ
aijmsr-196	63	28	muscle	muscle	NOUN
aijmsr-196	63	29	cells	cell	NOUN
aijmsr-196	63	30	into	into	ADP
aijmsr-196	63	31	the	the	DET
aijmsr-196	63	32	vessel	vessel	NOUN
aijmsr-196	63	33	wall	wall	PROPN
aijmsr-196	63	34	’s	’s	PART
aijmsr-196	63	35	intima	intima	NOUN
aijmsr-196	63	36	which	which	PRON
aijmsr-196	63	37	leads	lead	VERB
aijmsr-196	63	38	to	to	ADP
aijmsr-196	63	39	plaque	plaque	NOUN
aijmsr-196	63	40	formation	formation	NOUN
aijmsr-196	63	41	.	.	PUNCT
aijmsr-196	64	1	12	12	NUM
aijmsr-196	64	2	on	on	ADP
aijmsr-196	64	3	the	the	DET
aijmsr-196	64	4	other	other	ADJ
aijmsr-196	64	5	hand	hand	NOUN
aijmsr-196	64	6	,	,	PUNCT
aijmsr-196	64	7	however	however	ADV
aijmsr-196	64	8	,	,	PUNCT
aijmsr-196	64	9	mmp-10	mmp-10	PRON
aijmsr-196	64	10	contributes	contribute	VERB
aijmsr-196	64	11	also	also	ADV
aijmsr-196	64	12	to	to	ADP
aijmsr-196	64	13	plaque	plaque	NOUN
aijmsr-196	64	14	volume	volume	NOUN
aijmsr-196	64	15	diminishing	diminish	VERB
aijmsr-196	64	16	through	through	ADP
aijmsr-196	64	17	degradation	degradation	NOUN
aijmsr-196	64	18	of	of	ADP
aijmsr-196	64	19	extracellular	extracellular	ADJ
aijmsr-196	64	20	matrix	matrix	NOUN
aijmsr-196	64	21	in	in	ADP
aijmsr-196	64	22	the	the	DET
aijmsr-196	64	23	intima	intima	NOUN
aijmsr-196	64	24	.	.	PUNCT
aijmsr-196	65	1	13	13	NUM
aijmsr-196	65	2	this	this	PRON
aijmsr-196	65	3	explains	explain	VERB
aijmsr-196	65	4	the	the	DET
aijmsr-196	65	5	reduced	reduce	VERB
aijmsr-196	65	6	fibrous	fibrous	ADJ
aijmsr-196	65	7	content	content	NOUN
aijmsr-196	65	8	in	in	ADP
aijmsr-196	65	9	atherosclerotic	atherosclerotic	ADJ
aijmsr-196	65	10	plaques	plaque	NOUN
aijmsr-196	65	11	.	.	PUNCT
aijmsr-196	66	1	10	10	NUM
aijmsr-196	66	2	some	some	DET
aijmsr-196	66	3	studies	study	NOUN
aijmsr-196	66	4	have	have	AUX
aijmsr-196	66	5	shown	show	VERB
aijmsr-196	66	6	that	that	SCONJ
aijmsr-196	66	7	chronic	chronic	ADJ
aijmsr-196	66	8	conditions	condition	NOUN
aijmsr-196	66	9	such	such	ADJ
aijmsr-196	66	10	as	as	ADP
aijmsr-196	66	11	ckd	ckd	PROPN
aijmsr-196	66	12	often	often	ADV
aijmsr-196	66	13	underlie	underlie	VERB
aijmsr-196	66	14	very	very	ADV
aijmsr-196	66	15	severe	severe	ADJ
aijmsr-196	66	16	arterial	arterial	ADJ
aijmsr-196	66	17	disease	disease	NOUN
aijmsr-196	66	18	which	which	PRON
aijmsr-196	66	19	represents	represent	VERB
aijmsr-196	66	20	a	a	DET
aijmsr-196	66	21	high	high	ADJ
aijmsr-196	66	22	risk	risk	NOUN
aijmsr-196	66	23	in	in	ADP
aijmsr-196	66	24	patients	patient	NOUN
aijmsr-196	66	25	with	with	ADP
aijmsr-196	66	26	ckd	ckd	PROPN
aijmsr-196	66	27	with	with	ADP
aijmsr-196	66	28	primary	primary	ADJ
aijmsr-196	66	29	importance	importance	NOUN
aijmsr-196	66	30	both	both	CCONJ
aijmsr-196	66	31	for	for	ADP
aijmsr-196	66	32	public	public	ADJ
aijmsr-196	66	33	health	health	NOUN
aijmsr-196	66	34	and	and	CCONJ
aijmsr-196	66	35	for	for	ADP
aijmsr-196	66	36	clinical	clinical	ADJ
aijmsr-196	66	37	reasons	reason	NOUN
aijmsr-196	66	38	.	.	PUNCT
aijmsr-196	67	1	14	14	NUM
aijmsr-196	67	2	moreover	moreover	ADV
aijmsr-196	67	3	,	,	PUNCT
aijmsr-196	67	4	atherosclerosis	atherosclerosis	NOUN
aijmsr-196	67	5	is	be	AUX
aijmsr-196	67	6	10	10	NUM
aijmsr-196	67	7	-	-	SYM
aijmsr-196	67	8	20	20	NUM
aijmsr-196	67	9	times	time	NOUN
aijmsr-196	67	10	more	more	ADV
aijmsr-196	67	11	often	often	ADV
aijmsr-196	67	12	in	in	ADP
aijmsr-196	67	13	patients	patient	NOUN
aijmsr-196	67	14	with	with	ADP
aijmsr-196	67	15	ckd	ckd	PROPN
aijmsr-196	67	16	,	,	PUNCT
aijmsr-196	67	17	especially	especially	ADV
aijmsr-196	67	18	in	in	ADP
aijmsr-196	67	19	end	end	NOUN
aijmsr-196	67	20	-	-	PUNCT
aijmsr-196	67	21	stage	stage	NOUN
aijmsr-196	67	22	renal	renal	ADJ
aijmsr-196	67	23	disease	disease	NOUN
aijmsr-196	67	24	.	.	PUNCT
aijmsr-196	68	1	14	14	NUM
aijmsr-196	68	2	this	this	PRON
aijmsr-196	68	3	is	be	AUX
aijmsr-196	68	4	in	in	ADP
aijmsr-196	68	5	consistent	consistent	ADJ
aijmsr-196	68	6	with	with	ADP
aijmsr-196	68	7	our	our	PRON
aijmsr-196	68	8	findings	finding	NOUN
aijmsr-196	68	9	for	for	ADP
aijmsr-196	68	10	the	the	DET
aijmsr-196	68	11	highest	high	ADJ
aijmsr-196	68	12	level	level	NOUN
aijmsr-196	68	13	of	of	ADP
aijmsr-196	68	14	mmp-10	mmp-10	PROPN
aijmsr-196	68	15	in	in	ADP
aijmsr-196	68	16	ckd	ckd	PROPN
aijmsr-196	68	17	patients	patient	NOUN
aijmsr-196	68	18	on	on	ADP
aijmsr-196	68	19	chroniodialysis	chroniodialysis	NOUN
aijmsr-196	68	20	.	.	PUNCT
aijmsr-196	69	1	coll	coll	PROPN
aijmsr-196	69	2	et	et	PROPN
aijmsr-196	69	3	al	al	PROPN
aijmsr-196	69	4	.	.	PROPN
aijmsr-196	69	5	also	also	ADV
aijmsr-196	69	6	showed	show	VERB
aijmsr-196	69	7	that	that	SCONJ
aijmsr-196	69	8	serum	serum	NOUN
aijmsr-196	69	9	levels	level	NOUN
aijmsr-196	69	10	of	of	ADP
aijmsr-196	69	11	mmp-10	mmp-10	PROPN
aijmsr-196	69	12	were	be	AUX
aijmsr-196	69	13	associated	associate	VERB
aijmsr-196	69	14	with	with	ADP
aijmsr-196	69	15	the	the	DET
aijmsr-196	69	16	severity	severity	NOUN
aijmsr-196	69	17	of	of	ADP
aijmsr-196	69	18	atherosclerosis	atherosclerosis	NOUN
aijmsr-196	69	19	in	in	ADP
aijmsr-196	69	20	patients	patient	NOUN
aijmsr-196	69	21	with	with	ADP
aijmsr-196	69	22	ckd	ckd	PROPN
aijmsr-196	69	23	.	.	PROPN
aijmsr-196	69	24	10	10	NUM
aijmsr-196	70	1	it	it	PRON
aijmsr-196	70	2	is	be	AUX
aijmsr-196	70	3	suggested	suggest	VERB
aijmsr-196	70	4	that	that	SCONJ
aijmsr-196	70	5	at	at	ADP
aijmsr-196	70	6	early	early	ADJ
aijmsr-196	70	7	stages	stage	NOUN
aijmsr-196	70	8	mmps	mmp	NOUN
aijmsr-196	70	9	are	be	AUX
aijmsr-196	70	10	involved	involve	VERB
aijmsr-196	70	11	in	in	ADP
aijmsr-196	70	12	breakdown	breakdown	NOUN
aijmsr-196	70	13	of	of	ADP
aijmsr-196	70	14	the	the	DET
aijmsr-196	70	15	glomerular	glomerular	ADJ
aijmsr-196	70	16	basal	basal	ADJ
aijmsr-196	70	17	membrane	membrane	NOUN
aijmsr-196	70	18	,	,	PUNCT
aijmsr-196	70	19	whereas	whereas	SCONJ
aijmsr-196	70	20	at	at	ADP
aijmsr-196	70	21	later	later	ADJ
aijmsr-196	70	22	stages	stage	NOUN
aijmsr-196	70	23	,	,	PUNCT
aijmsr-196	70	24	they	they	PRON
aijmsr-196	70	25	contribute	contribute	VERB
aijmsr-196	70	26	to	to	ADP
aijmsr-196	70	27	extracellular	extracellular	ADJ
aijmsr-196	70	28	matrix	matrix	NOUN
aijmsr-196	70	29	removing	removing	NOUN
aijmsr-196	70	30	which	which	PRON
aijmsr-196	70	31	is	be	AUX
aijmsr-196	70	32	associated	associate	VERB
aijmsr-196	70	33	with	with	ADP
aijmsr-196	70	34	scarring	scarring	NOUN
aijmsr-196	70	35	and	and	CCONJ
aijmsr-196	70	36	fibrosis	fibrosis	NOUN
aijmsr-196	70	37	.	.	PUNCT
aijmsr-196	71	1	3	3	NUM
aijmsr-196	71	2	this	this	DET
aijmsr-196	71	3	model	model	NOUN
aijmsr-196	71	4	could	could	AUX
aijmsr-196	71	5	explain	explain	VERB
aijmsr-196	71	6	the	the	DET
aijmsr-196	71	7	relationship	relationship	NOUN
aijmsr-196	71	8	between	between	ADP
aijmsr-196	71	9	mmps	mmp	NOUN
aijmsr-196	71	10	and	and	CCONJ
aijmsr-196	71	11	proteinuria	proteinuria	NOUN
aijmsr-196	71	12	in	in	ADP
aijmsr-196	71	13	many	many	ADJ
aijmsr-196	71	14	pathological	pathological	ADJ
aijmsr-196	71	15	conditions	condition	NOUN
aijmsr-196	71	16	in	in	ADP
aijmsr-196	71	17	spite	spite	NOUN
aijmsr-196	71	18	that	that	SCONJ
aijmsr-196	71	19	the	the	DET
aijmsr-196	71	20	role	role	NOUN
aijmsr-196	71	21	of	of	ADP
aijmsr-196	71	22	mmps	mmp	NOUN
aijmsr-196	71	23	in	in	ADP
aijmsr-196	71	24	atherosclerosis	atherosclerosis	NOUN
aijmsr-196	71	25	and	and	CCONJ
aijmsr-196	71	26	proteinuria	proteinuria	NOUN
aijmsr-196	71	27	in	in	ADP
aijmsr-196	71	28	kidney	kidney	NOUN
aijmsr-196	71	29	disease	disease	NOUN
aijmsr-196	71	30	progression	progression	NOUN
aijmsr-196	71	31	is	be	AUX
aijmsr-196	71	32	not	not	PART
aijmsr-196	71	33	yet	yet	ADV
aijmsr-196	71	34	completely	completely	ADV
aijmsr-196	71	35	elucidated	elucidated	ADJ
aijmsr-196	71	36	.	.	PUNCT
aijmsr-196	72	1	3	3	NUM
aijmsr-196	72	2	other	other	ADJ
aijmsr-196	72	3	studies	study	NOUN
aijmsr-196	72	4	have	have	AUX
aijmsr-196	72	5	also	also	ADV
aijmsr-196	72	6	shown	show	VERB
aijmsr-196	72	7	that	that	SCONJ
aijmsr-196	72	8	expression	expression	NOUN
aijmsr-196	72	9	and	and	CCONJ
aijmsr-196	72	10	secretion	secretion	NOUN
aijmsr-196	72	11	of	of	ADP
aijmsr-196	72	12	mmp10	mmp10	PROPN
aijmsr-196	72	13	by	by	ADP
aijmsr-196	72	14	human	human	ADJ
aijmsr-196	72	15	endothelial	endothelial	NOUN
aijmsr-196	72	16	cells	cell	NOUN
aijmsr-196	72	17	could	could	AUX
aijmsr-196	72	18	be	be	AUX
aijmsr-196	72	19	induced	induce	VERB
aijmsr-196	72	20	by	by	ADP
aijmsr-196	72	21	different	different	ADJ
aijmsr-196	72	22	inflammatory	inflammatory	ADJ
aijmsr-196	72	23	and	and	CCONJ
aijmsr-196	72	24	prothrombotic	prothrombotic	ADJ
aijmsr-196	72	25	stimuli	stimulus	NOUN
aijmsr-196	72	26	.	.	PUNCT
aijmsr-196	73	1	14	14	NUM
aijmsr-196	73	2	-	-	SYM
aijmsr-196	73	3	16	16	NUM
aijmsr-196	73	4	zoccali	zoccali	PROPN
aijmsr-196	73	5	et	et	PROPN
aijmsr-196	73	6	al	al	PROPN
aijmsr-196	73	7	.	.	PROPN
aijmsr-196	73	8	have	have	AUX
aijmsr-196	73	9	considered	consider	VERB
aijmsr-196	73	10	mmps	mmp	NOUN
aijmsr-196	73	11	as	as	ADP
aijmsr-196	73	12	markers	marker	NOUN
aijmsr-196	73	13	for	for	ADP
aijmsr-196	73	14	angiogenesis	angiogenesis	NOUN
aijmsr-196	73	15	before	before	ADP
aijmsr-196	73	16	the	the	DET
aijmsr-196	73	17	onset	onset	NOUN
aijmsr-196	73	18	of	of	ADP
aijmsr-196	73	19	proteinuria	proteinuria	NOUN
aijmsr-196	73	20	and	and	CCONJ
aijmsr-196	73	21	markers	marker	NOUN
aijmsr-196	73	22	for	for	ADP
aijmsr-196	73	23	progression	progression	NOUN
aijmsr-196	73	24	of	of	ADP
aijmsr-196	73	25	ckd	ckd	PROPN
aijmsr-196	73	26	at	at	ADP
aijmsr-196	73	27	late	late	ADJ
aijmsr-196	73	28	stages	stage	NOUN
aijmsr-196	73	29	14	14	NUM
aijmsr-196	73	30	.	.	PUNCT
aijmsr-196	74	1	5	5	X
aijmsr-196	74	2	.	.	X
aijmsr-196	74	3	conclusion	conclusion	NOUN
aijmsr-196	74	4	what	what	PRON
aijmsr-196	74	5	causes	cause	VERB
aijmsr-196	74	6	these	these	DET
aijmsr-196	74	7	results	result	NOUN
aijmsr-196	74	8	we	we	PRON
aijmsr-196	74	9	can	can	AUX
aijmsr-196	74	10	only	only	ADV
aijmsr-196	74	11	speculate	speculate	VERB
aijmsr-196	74	12	,	,	PUNCT
aijmsr-196	74	13	but	but	CCONJ
aijmsr-196	74	14	it	it	PRON
aijmsr-196	74	15	is	be	AUX
aijmsr-196	74	16	possible	possible	ADJ
aijmsr-196	74	17	that	that	SCONJ
aijmsr-196	74	18	the	the	DET
aijmsr-196	74	19	increased	increase	VERB
aijmsr-196	74	20	levels	level	NOUN
aijmsr-196	74	21	of	of	ADP
aijmsr-196	74	22	mmp-10	mmp-10	PROPN
aijmsr-196	74	23	could	could	AUX
aijmsr-196	74	24	be	be	AUX
aijmsr-196	74	25	associated	associate	VERB
aijmsr-196	74	26	with	with	ADP
aijmsr-196	74	27	poor	poor	ADJ
aijmsr-196	74	28	prognosis	prognosis	NOUN
aijmsr-196	74	29	and	and	CCONJ
aijmsr-196	74	30	eventually	eventually	ADV
aijmsr-196	74	31	need	need	VERB
aijmsr-196	74	32	for	for	ADP
aijmsr-196	74	33	dialysis	dialysis	NOUN
aijmsr-196	74	34	treatment	treatment	NOUN
aijmsr-196	74	35	at	at	ADP
aijmsr-196	74	36	earlier	early	ADJ
aijmsr-196	74	37	stages	stage	NOUN
aijmsr-196	74	38	.	.	PUNCT
aijmsr-196	75	1	we	we	PRON
aijmsr-196	75	2	hypothesize	hypothesize	VERB
aijmsr-196	75	3	that	that	SCONJ
aijmsr-196	75	4	ckd	ckd	PROPN
aijmsr-196	75	5	is	be	AUX
aijmsr-196	75	6	associated	associate	VERB
aijmsr-196	75	7	with	with	ADP
aijmsr-196	75	8	alterations	alteration	NOUN
aijmsr-196	75	9	of	of	ADP
aijmsr-196	75	10	mmps	mmp	NOUN
aijmsr-196	75	11	and	and	CCONJ
aijmsr-196	75	12	that	that	PRON
aijmsr-196	75	13	may	may	AUX
aijmsr-196	75	14	be	be	AUX
aijmsr-196	75	15	related	relate	VERB
aijmsr-196	75	16	to	to	ADP
aijmsr-196	75	17	the	the	DET
aijmsr-196	75	18	severity	severity	NOUN
aijmsr-196	75	19	of	of	ADP
aijmsr-196	75	20	atherosclerosis	atherosclerosis	NOUN
aijmsr-196	75	21	in	in	ADP
aijmsr-196	75	22	this	this	DET
aijmsr-196	75	23	clinical	clinical	ADJ
aijmsr-196	75	24	setting	setting	NOUN
aijmsr-196	75	25	.	.	PUNCT
aijmsr-196	76	1	furthermore	furthermore	ADV
aijmsr-196	76	2	,	,	PUNCT
aijmsr-196	76	3	the	the	DET
aijmsr-196	76	4	role	role	NOUN
aijmsr-196	76	5	of	of	ADP
aijmsr-196	76	6	mmps	mmp	NOUN
aijmsr-196	76	7	in	in	ADP
aijmsr-196	76	8	renal	renal	ADJ
aijmsr-196	76	9	diseases	disease	NOUN
aijmsr-196	76	10	,	,	PUNCT
aijmsr-196	76	11	proteinuria	proteinuria	NOUN
aijmsr-196	76	12	and	and	CCONJ
aijmsr-196	76	13	atherosclerosis	atherosclerosis	NOUN
aijmsr-196	76	14	may	may	AUX
aijmsr-196	76	15	lead	lead	VERB
aijmsr-196	76	16	to	to	ADP
aijmsr-196	76	17	the	the	DET
aijmsr-196	76	18	development	development	NOUN
aijmsr-196	76	19	of	of	ADP
aijmsr-196	76	20	new	new	ADJ
aijmsr-196	76	21	therapeutic	therapeutic	ADJ
aijmsr-196	76	22	approaches	approach	NOUN
aijmsr-196	76	23	for	for	ADP
aijmsr-196	76	24	future	future	ADJ
aijmsr-196	76	25	perspectives	perspective	NOUN
aijmsr-196	76	26	.	.	PUNCT
aijmsr-196	77	1	acknowledgment	acknowledgment	NOUN
aijmsr-196	77	2	this	this	DET
aijmsr-196	77	3	work	work	NOUN
aijmsr-196	77	4	was	be	AUX
aijmsr-196	77	5	supported	support	VERB
aijmsr-196	77	6	by	by	ADP
aijmsr-196	77	7	medical	medical	ADJ
aijmsr-196	77	8	university	university	PROPN
aijmsr-196	77	9	of	of	ADP
aijmsr-196	77	10	sofia	sofia	PROPN
aijmsr-196	78	1	[	[	X
aijmsr-196	78	2	grant	grant	X
aijmsr-196	78	3	funding	funding	NOUN
aijmsr-196	78	4	for	for	ADP
aijmsr-196	78	5	young	young	ADJ
aijmsr-196	78	6	investigator	investigator	NOUN
aijmsr-196	78	7	№	№	ADJ
aijmsr-196	78	8	11d/2013	11d/2013	NUM
aijmsr-196	78	9	,	,	PUNCT
aijmsr-196	78	10	project	project	NOUN
aijmsr-196	78	11	№	№	ADP
aijmsr-196	78	12	27d/2013	27d/2013	NUM
aijmsr-196	78	13	]	]	PUNCT
aijmsr-196	78	14	.	.	PUNCT
aijmsr-196	79	1	declaration	declaration	NOUN
aijmsr-196	79	2	of	of	ADP
aijmsr-196	79	3	conflicting	conflicting	ADJ
aijmsr-196	79	4	interests	interest	NOUN
aijmsr-196	79	5	the	the	DET
aijmsr-196	79	6	authors	author	NOUN
aijmsr-196	79	7	declare	declare	VERB
aijmsr-196	79	8	that	that	SCONJ
aijmsr-196	79	9	there	there	PRON
aijmsr-196	79	10	is	be	VERB
aijmsr-196	79	11	no	no	DET
aijmsr-196	79	12	conflict	conflict	NOUN
aijmsr-196	79	13	of	of	ADP
aijmsr-196	79	14	interest	interest	NOUN
aijmsr-196	79	15	references	reference	NOUN
aijmsr-196	79	16	1	1	NUM
aijmsr-196	79	17	.	.	PUNCT
aijmsr-196	80	1	nagase	nagase	PROPN
aijmsr-196	80	2	h	h	PROPN
aijmsr-196	80	3	,	,	PUNCT
aijmsr-196	80	4	woessner	woessner	PROPN
aijmsr-196	80	5	jr	jr	PROPN
aijmsr-196	80	6	jf	jf	PROPN
aijmsr-196	80	7	.	.	PROPN
aijmsr-196	80	8	matrix	matrix	NOUN
aijmsr-196	80	9	metalloproteinases	metalloproteinase	NOUN
aijmsr-196	80	10	.	.	PUNCT
aijmsr-196	81	1	j	j	PROPN
aijmsr-196	81	2	biol	biol	PROPN
aijmsr-196	81	3	chem	chem	NOUN
aijmsr-196	81	4	1999	1999	NUM
aijmsr-196	81	5	;	;	PUNCT
aijmsr-196	81	6	274	274	NUM
aijmsr-196	81	7	:	:	SYM
aijmsr-196	81	8	21491–21494	21491–21494	NUM
aijmsr-196	81	9	.	.	PUNCT
aijmsr-196	82	1	2.ronco	2.ronco	NUM
aijmsr-196	82	2	p	p	NOUN
aijmsr-196	82	3	,	,	PUNCT
aijmsr-196	82	4	lelongt	lelongt	PROPN
aijmsr-196	82	5	b	b	PROPN
aijmsr-196	82	6	,	,	PUNCT
aijmsr-196	82	7	piedagnel	piedagnel	NOUN
aijmsr-196	82	8	r	r	NOUN
aijmsr-196	82	9	,	,	PUNCT
aijmsr-196	82	10	chatziantoniou	chatziantoniou	NOUN
aijmsr-196	82	11	c.	c.	NOUN
aijmsr-196	82	12	matrix	matrix	NOUN
aijmsr-196	82	13	metalloproteinases	metalloproteinase	NOUN
aijmsr-196	82	14	in	in	ADP
aijmsr-196	82	15	kidney	kidney	NOUN
aijmsr-196	82	16	disease	disease	NOUN
aijmsr-196	82	17	progression	progression	NOUN
aijmsr-196	82	18	and	and	CCONJ
aijmsr-196	82	19	repair	repair	NOUN
aijmsr-196	82	20	:	:	PUNCT
aijmsr-196	82	21	a	a	DET
aijmsr-196	82	22	case	case	NOUN
aijmsr-196	82	23	of	of	ADP
aijmsr-196	82	24	flipping	flip	VERB
aijmsr-196	82	25	the	the	DET
aijmsr-196	82	26	coin	coin	NOUN
aijmsr-196	82	27	.	.	PUNCT
aijmsr-196	83	1	semin	semin	PROPN
aijmsr-196	83	2	nephrol	nephrol	PROPN
aijmsr-196	83	3	.	.	PUNCT
aijmsr-196	84	1	2007	2007	NUM
aijmsr-196	84	2	;	;	PUNCT
aijmsr-196	84	3	27	27	NUM
aijmsr-196	84	4	:	:	PUNCT
aijmsr-196	84	5	352	352	NUM
aijmsr-196	84	6	-	-	SYM
aijmsr-196	84	7	362	362	NUM
aijmsr-196	84	8	.	.	PUNCT
aijmsr-196	85	1	3	3	X
aijmsr-196	85	2	.	.	X
aijmsr-196	85	3	dimas	dimas	PROPN
aijmsr-196	85	4	g	g	PROPN
aijmsr-196	85	5	,	,	PUNCT
aijmsr-196	85	6	iliadis	iliadi	VERB
aijmsr-196	85	7	f	f	NUM
aijmsr-196	85	8	,	,	PUNCT
aijmsr-196	85	9	grekas	grekas	PROPN
aijmsr-196	85	10	d.	d.	PROPN
aijmsr-196	85	11	matrix	matrix	NOUN
aijmsr-196	85	12	metalloproteinases	metalloproteinase	NOUN
aijmsr-196	85	13	,	,	PUNCT
aijmsr-196	85	14	atherosclerosis	atherosclerosis	NOUN
aijmsr-196	85	15	,	,	PUNCT
aijmsr-196	85	16	proteinuria	proteinuria	NOUN
aijmsr-196	85	17	and	and	CCONJ
aijmsr-196	85	18	kidney	kidney	NOUN
aijmsr-196	85	19	disease	disease	NOUN
aijmsr-196	85	20	:	:	PUNCT
aijmsr-196	85	21	linkage	linkage	NOUN
aijmsr-196	85	22	–	–	PUNCT
aijmsr-196	85	23	based	base	VERB
aijmsr-196	85	24	approaches	approach	NOUN
aijmsr-196	85	25	.	.	PUNCT
aijmsr-196	86	1	hippokratia	hippokratia	NOUN
aijmsr-196	86	2	.	.	PUNCT
aijmsr-196	87	1	2013;17(4):292	2013;17(4):292	NUM
aijmsr-196	87	2	-	-	SYM
aijmsr-196	87	3	297	297	NUM
aijmsr-196	87	4	.	.	PUNCT
aijmsr-196	88	1	4	4	X
aijmsr-196	88	2	.	.	X
aijmsr-196	88	3	catania	catania	PROPN
aijmsr-196	88	4	jm	jm	PROPN
aijmsr-196	88	5	,	,	PUNCT
aijmsr-196	88	6	chen	chen	PROPN
aijmsr-196	88	7	g	g	PROPN
aijmsr-196	88	8	,	,	PUNCT
aijmsr-196	88	9	parrish	parrish	PROPN
aijmsr-196	88	10	ar	ar	PROPN
aijmsr-196	88	11	.	.	PROPN
aijmsr-196	88	12	role	role	NOUN
aijmsr-196	88	13	of	of	ADP
aijmsr-196	88	14	matrix	matrix	NOUN
aijmsr-196	88	15	metalloproteinases	metalloproteinase	NOUN
aijmsr-196	88	16	in	in	ADP
aijmsr-196	88	17	renal	renal	ADJ
aijmsr-196	88	18	pathophysiologies	pathophysiologie	NOUN
aijmsr-196	88	19	.	.	PUNCT
aijmsr-196	89	1	am	be	AUX
aijmsr-196	89	2	j	j	PROPN
aijmsr-196	89	3	physiol	physiol	PROPN
aijmsr-196	89	4	renal	renal	PROPN
aijmsr-196	89	5	physiol	physiol	PROPN
aijmsr-196	89	6	.	.	PUNCT
aijmsr-196	90	1	2007	2007	NUM
aijmsr-196	90	2	;	;	PUNCT
aijmsr-196	90	3	292	292	NUM
aijmsr-196	90	4	:	:	PUNCT
aijmsr-196	91	1	f905	f905	PROPN
aijmsr-196	91	2	-	-	PUNCT
aijmsr-196	91	3	f911	f911	PROPN
aijmsr-196	91	4	.	.	PUNCT
aijmsr-196	92	1	copyright	copyright	NOUN
aijmsr-196	93	1	©	©	PROPN
aijmsr-196	93	2	cc	cc	PROPN
aijmsr-196	93	3	-	-	PUNCT
aijmsr-196	93	4	by	by	ADP
aijmsr-196	93	5	-	-	PUNCT
aijmsr-196	93	6	nc	nc	PROPN
aijmsr-196	93	7	2018	2018	NUM
aijmsr-196	93	8	,	,	PUNCT
aijmsr-196	93	9	cribfb	cribfb	VERB
aijmsr-196	93	10	|	|	CCONJ
aijmsr-196	93	11	aijmsr	aijmsr	NOUN
aijmsr-196	93	12	www.cribfb.com/journal/index.php/aijmsr	www.cribfb.com/journal/index.php/aijmsr	VERB
aijmsr-196	93	13	american	american	PROPN
aijmsr-196	93	14	international	international	PROPN
aijmsr-196	93	15	journal	journal	PROPN
aijmsr-196	93	16	of	of	ADP
aijmsr-196	93	17	multidisciplinary	multidisciplinary	ADJ
aijmsr-196	93	18	scientific	scientific	ADJ
aijmsr-196	93	19	research	research	NOUN
aijmsr-196	93	20	vol	vol	NOUN
aijmsr-196	93	21	.	.	PROPN
aijmsr-196	94	1	4	4	NUM
aijmsr-196	94	2	,	,	PUNCT
aijmsr-196	94	3	no	no	INTJ
aijmsr-196	94	4	.	.	NOUN
aijmsr-196	94	5	1	1	NUM
aijmsr-196	94	6	;	;	PUNCT
aijmsr-196	94	7	2018	2018	NUM
aijmsr-196	94	8	21	21	NUM
aijmsr-196	94	9	5	5	NUM
aijmsr-196	94	10	.	.	PUNCT
aijmsr-196	95	1	xue	xue	PROPN
aijmsr-196	95	2	m	m	PROPN
aijmsr-196	95	3	,	,	PUNCT
aijmsr-196	95	4	thompson	thompson	PROPN
aijmsr-196	95	5	pj	pj	PROPN
aijmsr-196	95	6	,	,	PUNCT
aijmsr-196	95	7	clifton	clifton	PROPN
aijmsr-196	95	8	-	-	PUNCT
aijmsr-196	95	9	bligh	bligh	PROPN
aijmsr-196	95	10	r	r	PROPN
aijmsr-196	95	11	,	,	PUNCT
aijmsr-196	95	12	fulcher	fulcher	ADJ
aijmsr-196	95	13	g	g	NOUN
aijmsr-196	95	14	,	,	PUNCT
aijmsr-196	95	15	gallery	gallery	PROPN
aijmsr-196	95	16	ed	ed	PROPN
aijmsr-196	95	17	,	,	PUNCT
aijmsr-196	95	18	jackson	jackson	PROPN
aijmsr-196	95	19	c.	c.	PROPN
aijmsr-196	95	20	leucocyte	leucocyte	PROPN
aijmsr-196	95	21	matrix	matrix	NOUN
aijmsr-196	95	22	metalloproteinase-9	metalloproteinase-9	NUM
aijmsr-196	95	23	is	be	AUX
aijmsr-196	95	24	evelated	evelate	VERB
aijmsr-196	95	25	and	and	CCONJ
aijmsr-196	95	26	contributes	contribute	VERB
aijmsr-196	95	27	to	to	ADP
aijmsr-196	95	28	lemphocyte	lemphocyte	NOUN
aijmsr-196	95	29	activation	activation	NOUN
aijmsr-196	95	30	of	of	ADP
aijmsr-196	95	31	type	type	NOUN
aijmsr-196	95	32	i	i	PRON
aijmsr-196	95	33	diabetes	diabete	VERB
aijmsr-196	95	34	.	.	PUNCT
aijmsr-196	96	1	int	int	PROPN
aijmsr-196	96	2	j	j	PROPN
aijmsr-196	96	3	biochem	biochem	PROPN
aijmsr-196	96	4	cell	cell	NOUN
aijmsr-196	96	5	biol	biol	PROPN
aijmsr-196	96	6	.	.	PUNCT
aijmsr-196	97	1	2005	2005	NUM
aijmsr-196	97	2	;	;	PUNCT
aijmsr-196	97	3	37	37	NUM
aijmsr-196	97	4	:	:	SYM
aijmsr-196	97	5	2406	2406	NUM
aijmsr-196	97	6	-	-	SYM
aijmsr-196	97	7	2416	2416	NUM
aijmsr-196	97	8	.	.	PUNCT
aijmsr-196	98	1	6	6	NUM
aijmsr-196	98	2	.	.	X
aijmsr-196	98	3	brown	brown	PROPN
aijmsr-196	98	4	dl	dl	PROPN
aijmsr-196	98	5	,	,	PUNCT
aijmsr-196	98	6	hibbs	hibbs	PROPN
aijmsr-196	98	7	ms	ms	PROPN
aijmsr-196	98	8	,	,	PUNCT
aijmsr-196	98	9	kearney	kearney	PROPN
aijmsr-196	98	10	m	m	PROPN
aijmsr-196	98	11	,	,	PUNCT
aijmsr-196	98	12	loushin	loushin	PROPN
aijmsr-196	98	13	c	c	PROPN
aijmsr-196	98	14	,	,	PUNCT
aijmsr-196	98	15	isner	isner	PROPN
aijmsr-196	98	16	jm	jm	PROPN
aijmsr-196	98	17	.	.	PROPN
aijmsr-196	98	18	identification	identification	NOUN
aijmsr-196	98	19	of	of	ADP
aijmsr-196	98	20	92	92	NUM
aijmsr-196	98	21	-	-	PUNCT
aijmsr-196	98	22	kd	kd	NOUN
aijmsr-196	98	23	gelatinase	gelatinase	NOUN
aijmsr-196	98	24	in	in	ADP
aijmsr-196	98	25	human	human	ADJ
aijmsr-196	98	26	coronary	coronary	ADJ
aijmsr-196	98	27	atherosclerotic	atherosclerotic	ADJ
aijmsr-196	98	28	lesions	lesion	NOUN
aijmsr-196	98	29	:	:	PUNCT
aijmsr-196	98	30	association	association	NOUN
aijmsr-196	98	31	of	of	ADP
aijmsr-196	98	32	active	active	ADJ
aijmsr-196	98	33	enzyme	enzyme	NOUN
aijmsr-196	98	34	synthesis	synthesis	NOUN
aijmsr-196	98	35	with	with	ADP
aijmsr-196	98	36	unstable	unstable	ADJ
aijmsr-196	98	37	angina	angina	NOUN
aijmsr-196	98	38	.	.	PUNCT
aijmsr-196	99	1	circulation	circulation	NOUN
aijmsr-196	99	2	1995	1995	NUM
aijmsr-196	99	3	;	;	PUNCT
aijmsr-196	99	4	91	91	NUM
aijmsr-196	99	5	:	:	SYM
aijmsr-196	99	6	2125–2131	2125–2131	NUM
aijmsr-196	99	7	.	.	PUNCT
aijmsr-196	100	1	7	7	X
aijmsr-196	100	2	.	.	X
aijmsr-196	100	3	agewall	agewall	PROPN
aijmsr-196	100	4	s.	s.	PROPN
aijmsr-196	100	5	matrix	matrix	NOUN
aijmsr-196	100	6	metalloproteinases	metalloproteinase	NOUN
aijmsr-196	100	7	and	and	CCONJ
aijmsr-196	100	8	cardiovascular	cardiovascular	ADJ
aijmsr-196	100	9	disease	disease	NOUN
aijmsr-196	100	10	.	.	PUNCT
aijmsr-196	101	1	european	european	ADJ
aijmsr-196	101	2	heart	heart	PROPN
aijmsr-196	101	3	journal	journal	PROPN
aijmsr-196	101	4	.	.	PUNCT
aijmsr-196	102	1	2006	2006	NUM
aijmsr-196	102	2	;	;	PUNCT
aijmsr-196	102	3	27	27	NUM
aijmsr-196	102	4	:	:	PUNCT
aijmsr-196	102	5	121–122	121–122	NUM
aijmsr-196	102	6	.	.	NOUN
aijmsr-196	102	7	8	8	NUM
aijmsr-196	102	8	.	.	PUNCT
aijmsr-196	103	1	surendran	surendran	PROPN
aijmsr-196	103	2	k	k	PROPN
aijmsr-196	103	3	,	,	PUNCT
aijmsr-196	103	4	simon	simon	PROPN
aijmsr-196	103	5	tc	tc	PROPN
aijmsr-196	103	6	,	,	PUNCT
aijmsr-196	103	7	liapis	liapi	VERB
aijmsr-196	103	8	h	h	PROPN
aijmsr-196	103	9	,	,	PUNCT
aijmsr-196	103	10	mcguire	mcguire	PROPN
aijmsr-196	103	11	zk	zk	PROPN
aijmsr-196	103	12	.	.	PROPN
aijmsr-196	103	13	matrilysin	matrilysin	PROPN
aijmsr-196	103	14	(	(	PUNCT
aijmsr-196	103	15	mmp-7	mmp-7	NOUN
aijmsr-196	103	16	)	)	PUNCT
aijmsr-196	103	17	expression	expression	NOUN
aijmsr-196	103	18	in	in	ADP
aijmsr-196	103	19	renal	renal	ADJ
aijmsr-196	103	20	tubular	tubular	ADJ
aijmsr-196	103	21	damage	damage	NOUN
aijmsr-196	103	22	:	:	PUNCT
aijmsr-196	103	23	association	association	NOUN
aijmsr-196	103	24	with	with	ADP
aijmsr-196	103	25	wnt4	wnt4	PROPN
aijmsr-196	103	26	.	.	PUNCT
aijmsr-196	104	1	kidney	kidney	PROPN
aijmsr-196	104	2	international	international	PROPN
aijmsr-196	104	3	.	.	PUNCT
aijmsr-196	105	1	2004	2004	NUM
aijmsr-196	105	2	;	;	PUNCT
aijmsr-196	105	3	65	65	NUM
aijmsr-196	105	4	:	:	SYM
aijmsr-196	105	5	2212–2222	2212–2222	NUM
aijmsr-196	105	6	.	.	PUNCT
aijmsr-196	106	1	9.belal	9.belal	NUM
aijmsr-196	106	2	,	,	PUNCT
aijmsr-196	106	3	d.	d.	PROPN
aijmsr-196	106	4	,	,	PUNCT
aijmsr-196	106	5	m.	m.	PROPN
aijmsr-196	106	6	e.	e.	PROPN
aijmsr-196	106	7	deeb	deeb	PROPN
aijmsr-196	106	8	,	,	PUNCT
aijmsr-196	106	9	n.	n.	PROPN
aijmsr-196	106	10	adly	adly	PROPN
aijmsr-196	106	11	,	,	PUNCT
aijmsr-196	106	12	m.	m.	PROPN
aijmsr-196	106	13	mostafa	mostafa	PROPN
aijmsr-196	106	14	,	,	PUNCT
aijmsr-196	106	15	k.	k.	PROPN
aijmsr-196	106	16	kaffas	kaffas	PROPN
aijmsr-196	106	17	,	,	PUNCT
aijmsr-196	106	18	and	and	CCONJ
aijmsr-196	106	19	n.	n.	PROPN
aijmsr-196	106	20	mohammed	mohammed	PROPN
aijmsr-196	106	21	,	,	PUNCT
aijmsr-196	106	22	"	"	PUNCT
aijmsr-196	106	23	the	the	DET
aijmsr-196	106	24	relationship	relationship	NOUN
aijmsr-196	106	25	between	between	ADP
aijmsr-196	106	26	matrix	matrix	NOUN
aijmsr-196	106	27	metalloproteinase-10	metalloproteinase-10	PROPN
aijmsr-196	106	28	(	(	PUNCT
aijmsr-196	106	29	mmp-10	mmp-10	PROPN
aijmsr-196	106	30	)	)	PUNCT
aijmsr-196	106	31	and	and	CCONJ
aijmsr-196	106	32	atherosclerosis	atherosclerosis	NOUN
aijmsr-196	106	33	in	in	ADP
aijmsr-196	106	34	patients	patient	NOUN
aijmsr-196	106	35	with	with	ADP
aijmsr-196	106	36	chronic	chronic	ADJ
aijmsr-196	106	37	kidney	kidney	NOUN
aijmsr-196	106	38	disease	disease	NOUN
aijmsr-196	106	39	"	"	PUNCT
aijmsr-196	106	40	.	.	PUNCT
aijmsr-196	107	1	international	international	ADJ
aijmsr-196	107	2	journal	journal	PROPN
aijmsr-196	107	3	of	of	ADP
aijmsr-196	107	4	advanced	advanced	ADJ
aijmsr-196	107	5	research	research	NOUN
aijmsr-196	107	6	(	(	PUNCT
aijmsr-196	107	7	ijar	ijar	NOUN
aijmsr-196	107	8	)	)	PUNCT
aijmsr-196	107	9	.	.	PUNCT
aijmsr-196	108	1	2014	2014	NUM
aijmsr-196	108	2	.	.	PUNCT
aijmsr-196	109	1	10	10	NUM
aijmsr-196	109	2	.	.	PUNCT
aijmsr-196	110	1	coll	coll	PROPN
aijmsr-196	110	2	b	b	PROPN
aijmsr-196	110	3	,	,	PUNCT
aijmsr-196	110	4	rodrıguez	rodrıguez	NOUN
aijmsr-196	110	5	ja	ja	PROPN
aijmsr-196	110	6	,	,	PUNCT
aijmsr-196	110	7	craver	craver	NOUN
aijmsr-196	110	8	l	l	NOUN
aijmsr-196	110	9	et	et	PROPN
aijmsr-196	111	1	al	al	PROPN
aijmsr-196	111	2	.	.	PROPN
aijmsr-196	111	3	serum	serum	PROPN
aijmsr-196	111	4	levels	level	NOUN
aijmsr-196	111	5	of	of	ADP
aijmsr-196	111	6	matrix	matrix	NOUN
aijmsr-196	111	7	metalloproteinase-10	metalloproteinase-10	PROPN
aijmsr-196	111	8	are	be	AUX
aijmsr-196	111	9	associated	associate	VERB
aijmsr-196	111	10	with	with	ADP
aijmsr-196	111	11	the	the	DET
aijmsr-196	111	12	severity	severity	NOUN
aijmsr-196	111	13	of	of	ADP
aijmsr-196	111	14	atherosclerosis	atherosclerosis	NOUN
aijmsr-196	111	15	in	in	ADP
aijmsr-196	111	16	patients	patient	NOUN
aijmsr-196	111	17	with	with	ADP
aijmsr-196	111	18	chronic	chronic	ADJ
aijmsr-196	111	19	kidney	kidney	NOUN
aijmsr-196	111	20	disease	disease	NOUN
aijmsr-196	111	21	.	.	PUNCT
aijmsr-196	112	1	kidney	kidney	PROPN
aijmsr-196	112	2	international	international	PROPN
aijmsr-196	112	3	.	.	PUNCT
aijmsr-196	113	1	2010	2010	NUM
aijmsr-196	113	2	,	,	PUNCT
aijmsr-196	113	3	78	78	NUM
aijmsr-196	113	4	:	:	SYM
aijmsr-196	113	5	1275	1275	NUM
aijmsr-196	113	6	–	–	PUNCT
aijmsr-196	113	7	1280	1280	NUM
aijmsr-196	113	8	.	.	PUNCT
aijmsr-196	114	1	11.go	11.go	NUM
aijmsr-196	114	2	as	as	ADP
aijmsr-196	114	3	,	,	PUNCT
aijmsr-196	114	4	chertow	chertow	NOUN
aijmsr-196	114	5	gm	gm	PROPN
aijmsr-196	114	6	,	,	PUNCT
aijmsr-196	114	7	fan	fan	PROPN
aijmsr-196	114	8	d	d	X
aijmsr-196	114	9	et	et	PROPN
aijmsr-196	114	10	al	al	PROPN
aijmsr-196	114	11	.	.	PROPN
aijmsr-196	114	12	chronic	chronic	ADJ
aijmsr-196	114	13	kidney	kidney	NOUN
aijmsr-196	114	14	disease	disease	NOUN
aijmsr-196	114	15	and	and	CCONJ
aijmsr-196	114	16	the	the	DET
aijmsr-196	114	17	risks	risk	NOUN
aijmsr-196	114	18	of	of	ADP
aijmsr-196	114	19	death	death	NOUN
aijmsr-196	114	20	,	,	PUNCT
aijmsr-196	114	21	cardiovascular	cardiovascular	ADJ
aijmsr-196	114	22	events	event	NOUN
aijmsr-196	114	23	,	,	PUNCT
aijmsr-196	114	24	and	and	CCONJ
aijmsr-196	114	25	hospitalization	hospitalization	NOUN
aijmsr-196	114	26	.	.	PUNCT
aijmsr-196	115	1	n	n	PROPN
aijmsr-196	115	2	engl	engl	PROPN
aijmsr-196	115	3	j	j	PROPN
aijmsr-196	115	4	med	med	PROPN
aijmsr-196	115	5	2004	2004	NUM
aijmsr-196	115	6	;	;	PUNCT
aijmsr-196	115	7	351	351	NUM
aijmsr-196	115	8	:	:	SYM
aijmsr-196	115	9	1296–1305	1296–1305	NUM
aijmsr-196	115	10	.	.	PUNCT
aijmsr-196	116	1	erratum	erratum	PROPN
aijmsr-196	116	2	in	in	ADP
aijmsr-196	116	3	:	:	PUNCT
aijmsr-196	116	4	n	n	X
aijmsr-196	116	5	engl	engl	PROPN
aijmsr-196	116	6	j	j	PROPN
aijmsr-196	116	7	med	med	PROPN
aijmsr-196	116	8	2008	2008	NUM
aijmsr-196	116	9	;	;	PUNCT
aijmsr-196	116	10	18	18	NUM
aijmsr-196	116	11	:	:	SYM
aijmsr-196	116	12	4	4	NUM
aijmsr-196	116	13	.	.	NOUN
aijmsr-196	116	14	12	12	NUM
aijmsr-196	116	15	.	.	PUNCT
aijmsr-196	117	1	ravn	ravn	PROPN
aijmsr-196	117	2	hb	hb	PROPN
aijmsr-196	117	3	,	,	PUNCT
aijmsr-196	117	4	falk	falk	PROPN
aijmsr-196	117	5	e.	e.	PROPN
aijmsr-196	117	6	histopathology	histopathology	PROPN
aijmsr-196	117	7	of	of	ADP
aijmsr-196	117	8	plaque	plaque	NOUN
aijmsr-196	117	9	rupture	rupture	NOUN
aijmsr-196	117	10	.	.	PUNCT
aijmsr-196	118	1	cardiol	cardiol	PROPN
aijmsr-196	118	2	clin	clin	PROPN
aijmsr-196	118	3	1999	1999	NUM
aijmsr-196	118	4	;	;	PUNCT
aijmsr-196	118	5	17:263–270	17:263–270	NUM
aijmsr-196	118	6	.	.	PUNCT
aijmsr-196	119	1	13.ardans	13.ardans	NUM
aijmsr-196	120	1	ja	ja	PROPN
aijmsr-196	120	2	,	,	PUNCT
aijmsr-196	120	3	blum	blum	PROPN
aijmsr-196	120	4	a	a	PROPN
aijmsr-196	120	5	,	,	PUNCT
aijmsr-196	120	6	mangan	mangan	PROPN
aijmsr-196	120	7	pr	pr	PROPN
aijmsr-196	120	8	,	,	PUNCT
aijmsr-196	120	9	wientroub	wientroub	NOUN
aijmsr-196	120	10	s	s	PROPN
aijmsr-196	120	11	,	,	PUNCT
aijmsr-196	120	12	cannon	cannon	NOUN
aijmsr-196	120	13	ro	ro	NOUN
aijmsr-196	120	14	iii	iii	PROPN
aijmsr-196	120	15	,	,	PUNCT
aijmsr-196	120	16	wahl	wahl	PROPN
aijmsr-196	120	17	lm	lm	PROPN
aijmsr-196	120	18	.	.	PUNCT
aijmsr-196	121	1	raloxifene	raloxifene	NOUN
aijmsr-196	121	2	-	-	PUNCT
aijmsr-196	121	3	mediated	mediate	VERB
aijmsr-196	121	4	increase	increase	NOUN
aijmsr-196	121	5	in	in	ADP
aijmsr-196	121	6	matrix	matrix	NOUN
aijmsr-196	121	7	metalloproteinase-1	metalloproteinase-1	NOUN
aijmsr-196	121	8	production	production	NOUN
aijmsr-196	121	9	by	by	ADP
aijmsr-196	121	10	activated	activate	VERB
aijmsr-196	121	11	monocytes	monocyte	NOUN
aijmsr-196	121	12	.	.	PUNCT
aijmsr-196	122	1	arterioscler	arterioscler	PROPN
aijmsr-196	122	2	thromb	thromb	PROPN
aijmsr-196	122	3	vasc	vasc	PROPN
aijmsr-196	122	4	biol	biol	PROPN
aijmsr-196	122	5	2001	2001	NUM
aijmsr-196	122	6	;	;	PUNCT
aijmsr-196	122	7	21	21	NUM
aijmsr-196	122	8	:	:	PUNCT
aijmsr-196	122	9	1265–1268	1265–1268	NUM
aijmsr-196	122	10	.	.	PUNCT
aijmsr-196	123	1	14	14	NUM
aijmsr-196	123	2	.	.	PUNCT
aijmsr-196	124	1	zoccali	zoccali	PROPN
aijmsr-196	124	2	c	c	PROPN
aijmsr-196	124	3	,	,	PUNCT
aijmsr-196	124	4	seck	seck	PROPN
aijmsr-196	124	5	s.	s.	PROPN
aijmsr-196	125	1	what	what	PRON
aijmsr-196	125	2	makes	make	VERB
aijmsr-196	125	3	plaques	plaque	NOUN
aijmsr-196	125	4	vulnerable	vulnerable	ADJ
aijmsr-196	125	5	in	in	ADP
aijmsr-196	125	6	ckd	ckd	PROPN
aijmsr-196	125	7	?	?	PUNCT
aijmsr-196	125	8	:	:	PUNCT
aijmsr-196	125	9	a	a	DET
aijmsr-196	125	10	fresh	fresh	ADJ
aijmsr-196	125	11	look	look	NOUN
aijmsr-196	125	12	at	at	ADP
aijmsr-196	125	13	metalloproteinases	metalloproteinase	NOUN
aijmsr-196	125	14	.	.	PUNCT
aijmsr-196	126	1	kidney	kidney	PROPN
aijmsr-196	126	2	international	international	PROPN
aijmsr-196	126	3	.	.	PUNCT
aijmsr-196	127	1	2010	2010	NUM
aijmsr-196	127	2	;	;	PUNCT
aijmsr-196	127	3	78	78	NUM
aijmsr-196	127	4	:	:	SYM
aijmsr-196	127	5	1206–1208	1206–1208	NUM
aijmsr-196	127	6	.	.	PUNCT
aijmsr-196	128	1	15	15	NUM
aijmsr-196	128	2	.	.	PUNCT
aijmsr-196	129	1	orbe	orbe	PROPN
aijmsr-196	129	2	j	j	PROPN
aijmsr-196	129	3	,	,	PUNCT
aijmsr-196	129	4	rodrıguez	rodrıguez	NOUN
aijmsr-196	129	5	ja	ja	PROPN
aijmsr-196	129	6	,	,	PUNCT
aijmsr-196	129	7	olivier	olivier	PROPN
aijmsr-196	129	8	c	c	PROPN
aijmsr-196	129	9	et	et	PROPN
aijmsr-196	129	10	al	al	PROPN
aijmsr-196	129	11	.	.	PROPN
aijmsr-196	129	12	matrix	matrix	NOUN
aijmsr-196	129	13	metalloproteinase-10	metalloproteinase-10	PROPN
aijmsr-196	129	14	(	(	PUNCT
aijmsr-196	129	15	mmp-10	mmp-10	PROPN
aijmsr-196	129	16	)	)	PUNCT
aijmsr-196	129	17	is	be	AUX
aijmsr-196	129	18	up	up	ADV
aijmsr-196	129	19	-	-	PUNCT
aijmsr-196	129	20	regulated	regulate	VERB
aijmsr-196	129	21	by	by	ADP
aijmsr-196	129	22	thrombin	thrombin	NOUN
aijmsr-196	129	23	in	in	ADP
aijmsr-196	129	24	endothelial	endothelial	ADJ
aijmsr-196	129	25	cells	cell	NOUN
aijmsr-196	129	26	and	and	CCONJ
aijmsr-196	129	27	increased	increase	VERB
aijmsr-196	129	28	in	in	ADP
aijmsr-196	129	29	patients	patient	NOUN
aijmsr-196	129	30	with	with	ADP
aijmsr-196	129	31	enhanced	enhanced	ADJ
aijmsr-196	129	32	thrombin	thrombin	NOUN
aijmsr-196	129	33	generation	generation	NOUN
aijmsr-196	129	34	.	.	PUNCT
aijmsr-196	130	1	arterioscler	arterioscler	PROPN
aijmsr-196	130	2	thromb	thromb	PROPN
aijmsr-196	130	3	vasc	vasc	PROPN
aijmsr-196	130	4	biol	biol	PROPN
aijmsr-196	130	5	.	.	PUNCT
aijmsr-196	131	1	2009	2009	NUM
aijmsr-196	131	2	;	;	PUNCT
aijmsr-196	131	3	29	29	NUM
aijmsr-196	131	4	:	:	SYM
aijmsr-196	131	5	2109–2116	2109–2116	NUM
aijmsr-196	131	6	.	.	PUNCT
aijmsr-196	132	1	16	16	NUM
aijmsr-196	132	2	.	.	PUNCT
aijmsr-196	133	1	orbe	orbe	PROPN
aijmsr-196	133	2	j	j	PROPN
aijmsr-196	133	3	,	,	PUNCT
aijmsr-196	133	4	montero	montero	PROPN
aijmsr-196	134	1	i	i	PROPN
aijmsr-196	134	2	,	,	PUNCT
aijmsr-196	134	3	rodrı	rodrı	ADJ
aijmsr-196	134	4	´	´	PROPN
aijmsr-196	134	5	guez	guez	PROPN
aijmsr-196	134	6	ja	ja	PROPN
aijmsr-196	134	7	et	et	PROPN
aijmsr-196	134	8	al	al	PROPN
aijmsr-196	134	9	.	.	PROPN
aijmsr-196	135	1	independent	independent	PROPN
aijmsr-196	135	2	association	association	PROPN
aijmsr-196	135	3	of	of	ADP
aijmsr-196	135	4	matrix	matrix	NOUN
aijmsr-196	135	5	metalloproteinase-10	metalloproteinase-10	PROPN
aijmsr-196	135	6	,	,	PUNCT
aijmsr-196	135	7	cardiovascular	cardiovascular	ADJ
aijmsr-196	135	8	risk	risk	NOUN
aijmsr-196	135	9	factors	factor	NOUN
aijmsr-196	135	10	and	and	CCONJ
aijmsr-196	135	11	subclinical	subclinical	ADJ
aijmsr-196	135	12	atherosclerosis	atherosclerosis	NOUN
aijmsr-196	135	13	.	.	PUNCT
aijmsr-196	136	1	j	j	PROPN
aijmsr-196	136	2	thromb	thromb	PROPN
aijmsr-196	136	3	haemost	haemost	VERB
aijmsr-196	136	4	.	.	PUNCT
aijmsr-196	137	1	2007	2007	NUM
aijmsr-196	137	2	;	;	PUNCT
aijmsr-196	137	3	5	5	NUM
aijmsr-196	137	4	:	:	SYM
aijmsr-196	137	5	91–97	91–97	NUM
aijmsr-196	137	6	.	.	PUNCT
aijmsr-196	138	1	copyrights	copyright	VERB
aijmsr-196	138	2	copyright	copyright	NOUN
aijmsr-196	138	3	for	for	ADP
aijmsr-196	138	4	this	this	DET
aijmsr-196	138	5	article	article	NOUN
aijmsr-196	138	6	is	be	AUX
aijmsr-196	138	7	retained	retain	VERB
aijmsr-196	138	8	by	by	ADP
aijmsr-196	138	9	the	the	DET
aijmsr-196	138	10	author(s	author(s	PROPN
aijmsr-196	138	11	)	)	PUNCT
aijmsr-196	138	12	,	,	PUNCT
aijmsr-196	138	13	with	with	ADP
aijmsr-196	138	14	first	first	ADJ
aijmsr-196	138	15	publication	publication	NOUN
aijmsr-196	138	16	rights	right	NOUN
aijmsr-196	138	17	granted	grant	VERB
aijmsr-196	138	18	to	to	ADP
aijmsr-196	138	19	the	the	DET
aijmsr-196	138	20	journal	journal	NOUN
aijmsr-196	138	21	.	.	PUNCT
aijmsr-196	139	1	this	this	PRON
aijmsr-196	139	2	is	be	AUX
aijmsr-196	139	3	an	an	DET
aijmsr-196	139	4	open	open	ADJ
aijmsr-196	139	5	-	-	PUNCT
aijmsr-196	139	6	access	access	NOUN
aijmsr-196	139	7	article	article	NOUN
aijmsr-196	139	8	distributed	distribute	VERB
aijmsr-196	139	9	under	under	ADP
aijmsr-196	139	10	the	the	DET
aijmsr-196	139	11	terms	term	NOUN
aijmsr-196	139	12	and	and	CCONJ
aijmsr-196	139	13	conditions	condition	NOUN
aijmsr-196	139	14	of	of	ADP
aijmsr-196	139	15	the	the	DET
aijmsr-196	139	16	creative	creative	ADJ
aijmsr-196	139	17	commons	common	NOUN
aijmsr-196	139	18	attribution	attribution	NOUN
aijmsr-196	139	19	license	license	NOUN
aijmsr-196	139	20	(	(	PUNCT
aijmsr-196	139	21	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	PROPN
aijmsr-196	139	22	)	)	PUNCT